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Abstract: 
 
 
Despite decades of research, efficient and accurate peptide and protein folding remains to be a 
problematic feat. This is largely due to difficulty in determining ubiquitous folding 
characteristics among diverse peptide sequences and in establishing an overarching theme in the 
folding process. Thus it is critical to the advancement of knowledge on the topic that novel 
sequences and frameworks of peptides continue to be studied. Conotoxins have proven to be 
excellent subjects of study as they are small, bioactive, and their activity is often highly 
dependent on achieving an appropriate fold. F/O-Conotoxins have garnered significant interest 
due to their selective and inhibitory properties at the norepinephrine transporter (NET) (1,2). 
Here we present a novel F/O-conotoxin, PnID, which unlike the previously reported members of 
this class, is expressed as two native disulfide isomers within the venom duct extract of Conus 
pennaceus. Additionally, synthetic production of this peptide resulted in one ribbon isomer and 
two distinct topological globular isomers (named PnID Isomer B and PnID Isomer RevB), in 
which their formation was later found to be individually controlled by the sequential order in 
which their two disulfide bonds were selectively formed. Only one of the globular isomers, PnID 
B, demonstrated a small amount activity at the monoamine transporters. The ribbon isomer, 
PnID A showed inhibition of the NET, with and IC50 of 10 µM. A second globular isomer (with 
reversed topology) PnID RevB, was separately produced and demonstrated no comparative 
inhibition.  NMR analysis and structure calculations revealed that the occurrence of these novel 
topological isomers maybe due to a difference in two properties: (1) disulfide bond orientation, 
with retention of same connectivity and (2) backbone flexibility. A critical turn between residues 
5-8 within PnID appears to be largely affected by disulfide bond formation, where the more 
active topology, PnID Isomer B possesses an increased chance of forming a J-turn, similar to the 
turn seen in F-conotoxin MrIA, whereas the inactive isomer, PnID Isomer RevB, appears to have 
a higher tendency to form an α-turn. The implication that disulfide bond connectivity alone may 
not be enough information for the efficient synthetic reproduction of all Conus derived toxins is 
novel and wide impacting; this then requires closer scrutiny to the physical orientation of 
disulfide bonds in respect to each other. These findings implicate how pharmacological 
selectivity and/or specificity may be influenced by the synthetic strategy in sequential selective 
disulfide bond formation. We believe these findings could have implications on the future of 
synthetically produced and rationally designed peptide drugs to enhance receptor-targeting 
selectivity and/or specificity. 
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Chapter 1: Introduction, Overview, and Objectives 
1.0 Introduction 
1.1.1 Peptides as therapeutics 
 
 The following section contains excerpts from my paper entitled “A 21st-century approach 
to age-old problems: the ascension of biologics in clinical therapeutics”.  
  
Peptides are short chains of polymerized amino acid monomers (generally <50) which are 
vitally important to many functions in the life of an organism such as: cell signaling, 
physiological regulation, structural maintenance, maintaining redox conditions, and often in 
venomous organisms they are used for capturing prey or self-defense (6-8). Since these 
molecules are used to control so many native systems in an organism, they are of interest as 
potential therapeutics.  
 
“Biologics” or natively produced peptides and proteins are becoming of increasingly 
significant interest within the pharmaceutical community because of their unique properties of 
potency and demonstrated lack of dangerous metabolites (9). Many examples of these 
compounds exist within the current US FDA approved pharmacopeia including cancer 
medications, analgesics, and birth control (as well as many others). In recent years advances in 
proteomics and genomics have provided a vast amount of information for the further 
characterization and synthesis of these once thought too complex and unviable molecules. 
Despite triumphs over past hurdles in the industry, the development of biologics remains to see a 
long road of trials before taking the place of mainstream therapeutics, a title which has long been 
held by small organic molecules (SOMs). 
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Figure 1: A comparison between the structures of two “biologic” based drugs, 
Prialt® (left) an FDA approved analgesic peptide, and trastuzumab (right) a 
monoclonal antibody used to treat breast cancer. 
 
Peptides, the smallest members of the class of biologics, provide an array of possibilities 
in terms of selectivity, are easily and inexpensively synthesized, and are often slightly more 
stable than the larger protein-based biologics, such as monoclonal antibodies (Figure 1) or 
hormones (10). Although many barriers exist in the development of peptide drugs such as 
increasing stability, anaphylaxis, and achieving efficient folds (the focus of which will be the 
topic of this dissertation), to date the current focus in the development of peptide drugs has been 
their lack of oral absorption (11). Recently, novel lipid and chemical delivery systems have been 
developed that are making peptide-based therapeutics increasingly more viable. Some examples 
of successful or future potential peptide drugs include: the conotoxin-derived morphine 
alternative Prialt®/Ziconotide/ω-conotoxin MVIIA (Jazz Pharmaceuticals) (12); the NMDA-
modulating potential antidepressant GLYX13 (Naurex Inc.) (13); the gp41-binding HIV entry 
inhibitor T-20 or Enfuvirtide (14); and the antibiotic peptide Coly-Mycin1 (colistin/polymyxin 
E; JHP Pharmaceuticals) (15). Peptide-based drugs, similar to that of their larger antibody-based 
cousins, are unique in that they have a high ability for selective targeting because of innate 
analogy to the receptors of the body. Unlike SOMs, it has been postulated that peptides have a 
higher potential to mimic the natural communication systems of an organism, conferring lower 
risk of toxicity (11). In fact, approximately 20% of peptide drugs come to market after surviving 
clinical trials, in comparison to only 10% for SOMs (15). This relatively high success rate has 
contributed to the re-evaluation and renewed enthusiasm for peptide-based therapeutics (and 
other biologics) within the pharmaceutical sector (11). Most current efforts focus on the 
development of orally active peptide-based drugs, with laboratories (both academic and 
17 
 
industrial) pursuing increased oral availability through differing forms of recombinant and 
synthetic chemistry techniques, as well as lipid-based and other protective delivery systems; 
however, peptide-based cancer vaccines are also an emerging field (16,17). Outside of liposome 
technology, a synthetic approach for peptides that has shown potential merit is N- to C-peptide 
backbone cyclization (18). The initial use of peptide cyclization to stabilize bioactive peptides is 
seen with the success of Integrilin1 (Eprifibatide; Millennium Pharmaceuticals), a bioengineered 
cyclic hepta-peptide antiplatelet drug derived from a venom protein found within the 
southeastern pygmy rattlesnake. Continued improvements in cyclic peptide (cyclotide) stability, 
which now progresses to stabilize oral delivery, will undoubtedly further increase the potential 
for peptide-based drugs. 
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1.1.2 Introduction to Conotoxins 
 
This section contains excerpts from my paper entitled “Conotoxins and their regulatory 
considerations”  
The venom of Conus sea snails (Figure 2) has evolved as an efficient means of prey 
incapacitation and as an effective defense mechanism (19). The deadly effects of this venomous 
cocktail are a direct result of conotoxins, small disulfide-rich peptides that are potent antagonists 
of a range neuronal receptors and ion channels. These bioactive peptides express selectivity 
towards their target receptors and are even able to discriminate between receptor subtypes. These 
properties are being utilized to design receptor-modulating ligands with potential therapeutic 
applications. Conotoxins are typically about 10–40 amino acids in length, but exhibit many 
motifs that are normally found in larger proteins. These structural features are stabilized by 
disulfide bonds generated from the abundance of cysteine moieties in its primary structure 
(19,20). Interestingly, these cysteine residues are found in predictable locations within a 
conotoxin’s sequence, giving rise to loops of known amino acid lengths, which influence their 
bioactivity (20,21). Although disulfide bonds play a major role in determining conotoxin 
structure activity relationships, assessing how they influence bioactivity of conotoxins should be 
handled on a case-by-case basis as they stabilize peptide structure in varying degrees. The 
number of disulfide isomers possible within a conotoxin is directly correlated with an increasing 
number of cysteines within a peptide sequence (22). Notably, when the disulfide bond 
connectivity of α-conotoxin AuIB was rearranged, the resulting ribbon isomer exhibited greater 
bioactivity than the globular native toxin (23). This finding is valuable to conotoxin 
bioengineering as it expands the repertoire of modifiable conotoxins to include non-native 
isomers. Despite their great sequence diversity, the cysteine frameworks of these bioactive 
peptides are quite predictable. For majority of conotoxins containing four cysteines, their 
cysteine framework is given by the formula (X)n1CiCii(X)n2Ciii(X)n3Civ(X)n4 (20). Interestingly, 
the number of amino acids in n2 and n3 of these conotoxin’s cysteine frameworks can have 
profound consequences in their selectivity toward a specific receptor class. Generally, α-
conotoxins with a 3/5 cysteine framework (n2 = 3 and n3 = 5) will target muscle nicotinic 
acetylcholine receptors (nAChRs) (24) while conotoxins with a 4/7 framework (n2 = 4 and n3 = 
7) will be specific for neuronal nAChRs (12,19,24,25). This has important implications regarding 
conotoxin classification. Conotoxins can be systematically ordered into superfamilies and further 
organized into families (sometimes referred to as classes). Superfamilies are based on disulfide 
bond framework patterns, while families are founded on their pharmacological target (19,26). 
Currently, there are twenty main conotoxin superfamilies and within these inclusive categories 
lie their respective families, often denoted as a single Greek letter prefix. These categories are 
rapidly expanding with the discovery of new conotoxins. 
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Figure 2: Conus textile, one of the many venomous cone snail species capable of 
producing a cocktail of bioactive peptides. 
 
Venom peptides from the Conus genus have long been studied for pharmaceutical 
potential on receptors related to a various human maladies including: severe pain (27), cancer 
progression (28), convulsions (29), and more, with the native peptide ω-conotoxin MVIIA 
(Marketed as Prialt®) being the first and only US FDA approved conotoxin therapeutic to date, 
being a completely unmodified form of the originally discovered toxin (30). Thousands of 
peptides have been characterized from Conus that encompass twelve different pharmacological 
targets (31,32) and have provided a wealth of information about peptide-receptor interactions. 
Further information about these targets and a discussion on the interest in conotoxins as possible 
medications to treat pain will be considered in Chapter 4. 
 
Short disulfide bonded peptides such as conotoxins may be considered novel biologics in 
that their size is highly manageable (< 30 amino acids) (31,32) in comparison to many currently 
used biologics e.g. monoclonal antibodies. In addition to their size they often exhibit a potency 
almost unheard of within the organic molecule class, as well as a high amount of selectivity (33).  
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Their selectivity is often explained as an element that is constantly refined by nature. Unlike 
many synthetic small molecules, biologics and native based molecules (synthetic peptides or 
proteins similar to the native form) have the advantage of naturally being selected by their 
environment as effective drugs. These characteristics make them optimal to study as future 
medications or receptor probes.  
 
One of the most important and well known aspects of conotoxins is their ability to 
selectively target ion channel subtypes (26). This dynamic receptor–ligand interaction can be 
utilized to understand subtle differences in the normal physiology of various ion channel 
subtypes. As such, conotoxins are viewed as valuable resources for phyla selective receptor 
probes. Phyla selectivity is commonly seen amongst individual conotoxins, representing their 
native predatory preferences (26). Many peptides isolated from a piscivorous (fish eating) cone 
snail such as Conus magus, will only display activity in receptor subtypes related to higher order 
organisms, whereas molluscivorous (mollusk eating) cone snails tend to produce conotoxins 
which target mollusk receptor subtypes (34). This type of selectivity can be greatly utilized in 
terms of creating safe and effective pesticides. Potential pesticides produced from the venoms of 
molluscivorous cone snails may provide compounds that could be naturally degraded by 
microorganisms without producing harmful byproducts or causing environmental damage (35). 
 
Not only are conotoxins studied for their naturally selected pharmacodynamic and 
pharmacokinetic properties, their surplus of post-translationally modified (PTM) residues and 
stabilizing interactions make them unique candidates for gaining insight into the rational design 
of future drugs. Like larger proteins, they often provide a high level of selectivity for particular 
molecular targets. However the much smaller size of these peptides provides them with better 
adsorption and distribution properties. Studying the unique properties of these peptides and 
building a database of stable motifs which may be used as molecular scaffolds or by 
understanding their pharmacophores or active binding regions and adding them chimerically into 
other scaffolds pushes the envelope in the field of rational drug design. An excellent example of 
this is a recent study carried out by D’Souza et al. (36) in which the inhibitor cysteine knot motif 
or ICK of an N- to C-terminally cyclized peptide known as Momordica cochinchinensis trypsin 
inhibitor-II (MCoTI-II) was used as a molecular scaffold for a novel cancer drug candidate. In 
this study the researchers removed the original inter-cysteine loop of the MCoTI-II containing 
the native pharmacophore and replaced it with the binding region of a COG peptide, a known 
inhibitor of the SET protein which is often over expressed in many cancers. The team was able to 
use the properties of several peptides to create a rationally designed chimeric drug to inhibit the 
growth of these cancer cells. 
 
In addition to the current interest of these peptides as probes or medications, potential 
exists for their break into the pesticide industry, as very few peptides have been isolated from 
molluscivorous species in contrast to the number isolated from piscivorous species. This is due 
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to the premise that it would be unlikely for a molluscivorous species to produce a potent peptide 
capable of effecting mammals. However it is likely that investigation into venom peptides 
derived from mollusk eating species could provide a new avenue for pesticide development 
through the discovery of biologics that are selective to invasive species.  
 
1.1.3 Oxidative Folding of Conotoxins 
 
The following section contains excerpts from my paper entitled “Incorporation of post-
translational modified amino acids as an approach to increase both chemical and biological 
diversity of conotoxins and conopeptides” 
 
Although much of the focus in the development of modern peptide therapeutics is on 
creating orally active drugs, one of the major drawbacks in developing peptides as therapeutics 
to date has been the selective formation of the appropriate disulfide bonds in an effective and 
efficient manner, and in turn the formation of the most biologically active motif. This motif 
formation has dictated the success of conotoxins as drug leads and plays a central role their 
receptor specificity and isoform selectivity (37). The primary structures of conotoxins reveal 
pattern-specific cysteine frameworks that generate loops responsible in part for their ultimate 
disulfide bond connections, final motif, and their receptor specificity (19,20,23). The peptide’s 
unique receptor–ligand interaction is contingent on well-defined tertiary structures stabilized by 
disulfide bonds. Generally, conotoxins contain 1–3 disulfide bonds; however, as many as ten 
have been observed. Few conopeptides have demonstrated an absence in disulfide bond content, 
although they have been observed (31,32).   
The smallest conotoxin observed in nature (by mass), α-conotoxin MIC, contains just 12 
αα, of which four (33 %) are cysteines involved in the formation of two disulfide bridges (38). 
The highest possible combination of disulfide bridges within a peptide may be calculated using 
the formula: 𝑝 = ௡!೙
మ!ଶ
೙
మ
, where p is the number of possible disulfide bridges and n is the number of 
cysteines present within the peptide. These connections can have several permutations that 
generate new peptide isomers with distinct pharmacological and kinetic properties (33). As such, 
disulfide bridges directly contribute to the efficacy and biological variability of conotoxins.  
 
Methods for the oxidative folding of conotoxins include a wide variety of synthetic and in 
vitro enzymatic techniques. Due to the commonplace of solid phase peptide synthesis (SPPS) in 
the production of conotoxins, the most popular techniques that are used to fold conotoxins are 
synthetic and are often complimentary to SPPS. The most common techniques include 
incubation in the presence of molecular oxygen in a buffer system such as 0.1 molar ammonium 
bicarbonate, incubation in a buffered system in the presence of glutathione (reduced/oxidized in 
a 2 to 1 ratio respectively), or the use of multiple orthogonal protecting strategies which can be 
22 
 
sequentially removed to create regio-selectively folded toxins. In addition many changes can be 
made to the buffering system to change the peptides interaction with the surrounding solvent to 
modify the energy barrier of particular folds, thus the diversity of folding may increase 
dependent on the addition of a particular chaotrope, a change in temperature, time, or ion pairing.  
 
Folding a conotoxin in a buffered system by way of molecular oxygen creates an 
environment that often allows for the greatest diversification of the final products. This 
phenomenon is due to the principle that the folding of these toxins generally occurs under 
particular redox systems controlled by the equilibrium of oxido-reductants within the cell of 
which the toxin is natively produced. In addition these cells generally contain protein disulfide 
isomerases or PDIs within their endoplasmic reticulum that act as molecular chaperones, 
allowing for the efficient folding of the thermodynamic products. Thus stripping the system 
down to primary sequence and solvent interactions with molecular oxygen reduces the efficiency 
of the folding process but results in a more diverse array of products, some of which may have 
unique properties (39).  
 
In contrast, folding a particular toxin in a glutathione based buffering system provides an 
in vitro environment that better mimics what is occurring in vivo. Oxidized and reduced 
glutathione concentration in the endoplasmic reticulum differ by approximately a 1:2 ratio (39), 
creating an environment which pushes the equilibrium of the oxidative folding process to favor 
that of the folded products, thereby causing a an amplification of the native-like material which 
is often the target product when studying these peptides.  
 
The oxidative folding of peptides and proteins in vitro can occur by two specific models 
known as the collapsed model and the framework model (39). In the collapsed model of folding, 
various kinetic isomers form in addition to the thermodynamic product causing a significant loss 
in material and results in a soup of crude products that are often difficult to purify. The 
alternative model known as the framework model is one in which a peptide will transition from a 
reduced to an oxidized state while shifting directly to a thermodynamic isomer.  In conotoxins 
both models have been observed and the preference of one folding mechanism to another is 
highly dependent on sequence variation.  
  
Regio-selective folding of conotoxins is a process undertaken when the target disulfide 
connectivity of the conotoxin of interest is known and needs to be produced in an efficient 
manner. This technique requires the use of multiple orthogonal protecting strategies when the 
toxin contains at least four or more cysteines. One of the most robust and common orthogonal 
protecting strategies for the production of a four cysteine containing conotoxin utilizing Fmoc 
based chemistry is the inclusion of two acid labile trityl groups and two acetamidomethyl groups 
or Acms. This strategy allows the chemist to de-protect each pair of cysteines and form 
disulfides in a step-wise manner often resulting in a cleaner and more efficient synthesis (39).  
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Despite the fact that disulfide bridges could theoretically be formed following the 
previously mentioned equation, random and spontaneous generation of all permutations is rarely 
ever seen. This is due to differences that can occur within peptides primary sequences such as 
electrostatic interactions or steric hindrance of the backbone (due to Ramachandran angles) or 
side chains.  Dominance of the fold is typically given to the lowest energy conformation. 
However, these yields can be greatly influenced by adding alcohols (40) or changing the 
environmental conditions as previously mentioned. Although the contribution of disulfide bonds 
to protein stability has been established, deletion of these cysteine bridges can have varying 
effects on biological activity. An example of this is seen in the work of Khoo et al. (41) in which 
they effectively induced a deletion of a single cystine bridge by substitution with Alanine in the 
16 αα µ-conotoxin KIIIA to generate the synthetic analog µ-KIIIA [C1A, C9A]. Despite having 
one less cysteine bridge, µ-KIIIA [C1A, C9A] exhibited comparable activity with native µ-KIIIA 
(3 disulfide bonds) toward rat Nav1.2 with KD values of 0.008 ± 0.002 µM and 0.005 ± 0.005 
µM, respectively. Nuclear Magnetic Resonance (NMR) data coupled with molecular dynamics 
(MD) modeling indicated that both µ-KIIIA [C1A, C9A] and its native counterpart exhibited the 
retention of a key α-helix essential in binding to Nav1.2 and Nav1.4 receptors. Parallel studies 
done with scorpion toxins exhibited comparable results (42,43). This finding suggests that 
biological activity of toxins is not absolutely dependent on disulfide bond stabilization for all 
toxins, implying that toxin activity can be induced with conservation of partial or native-like 
motifs stabilized by non-covalent interactions. 
 
In contrast, Flinn et al. (44) demonstrated that deletion of a disulfide bond through 
synthetic substitution of Cys15 and Cys26 of 27-residue ω-conotoxin GVIA (3 native disulfide 
bonds), with serine residues resulted in a 8,000-fold loss of potency, with no measurable activity 
at 10 µM in rat vas deferens assay. NMR analysis of peptide [Ser]15,26 ω-conotoxin GVIA 
revealed a loss of native structure, demonstrated by the existence of multiple isomers In solution 
and attributed to cis–trans isomerism of an amino acid stretch normally constrained by the 
deleted cystine bond.  
 
Although disulfide bond connectivity has proven to be a very important aspect for 
obtaining biologically active folds, during folding the possibility may arise for contortions or 
knots within the structure (also known as topologies) to occur which could considerably alter the 
fold of the peptide, and thus the activity. Although topologies have been reported in peptides 
with three or more disulfides, most of the literature describing novel cysteine rich toxins with 
two disulfides focuses on obtaining the correct disulfide bond and lacks information about 
possible topologies which may be present. In this work I present a novel peptide with unique 
folding characteristics which may provide new information about preferred disulfide 
connectivity, topology formation, or particular interactions which contribute to the peptide’s 
structure activity relationships or SARs.  
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In addition to disulfide bond formation, several other PTMs have been shown to increase 
the diversity of motif formation within conotoxins. These modifications often change 
intramolecular conditions or solvent interactions to adopt different folds. The two most 
commonplace of which are C-terminal amidation, which is the second most common PTM in 
conotoxins, and hydroxylation (21). 
 
C-terminal amidation is a PTM present at the C-terminus of peptides in which an amide group 
replaces the hydroxyl group of the carboxylic acid terminal. As seen with N-terminal 
pyroglutamic acid modification, this C-terminal modification affects the overall isoelectric point 
and net charge state, neutralizing the potential for deprotonation. C-terminal modification is 
typically achieved by enzymatically cleaving a flanking C-terminal Glycine at the N–C bond, 
thus creating a new C-terminal that retains the truncated remains of the original peptide bond 
from the neighboring C-terminal amino acid (45). The presence of C-terminal signal sequences 
such a pre-PTM Glycine is commonly observed in the genetic analysis of conotoxins (31,32). It 
is estimated that over 127 naturally occurring conopeptides contain a C-terminal amide. This 
encompasses a large number of gene superfamilies including: A, B, I1, I2, J, M, O1, O2, P, Q, S, 
T, and V superfamilies. C-terminal amidation has been shown to occur in vitro on short C-
terminal Glycine containing peptides incubated with peptidylglycine α-amidating enzyme (EC 
1.14.17.3), in an oxygen-rich environment and in the presence of reduced cofactors such as 
ascorbic acid (46). This reaction is thought to form a hydroxyl glycine intermediate before the 
reaction goes to completion. C-terminal amidation was first hypothesized as a PTM in α-
conotoxin GI, one of the earliest discovered venom peptides (24). Suspicion regarding the C-
terminal assignment was not clearly demonstrated until α-conotoxin GI was chemically 
synthesized a few years later (47). As originally observed in α-conotoxin GI, the presence of a C-
terminal amide may act to protect peptide toxins against carboxypeptidase activity, increasing 
the circulation half-life in prey (24). The importance of C-terminal amidation within conotoxins 
was further recognized in the early- to mid-1990s when studies were first being conducted to 
understand their contribution to disulfide arrangement and folding, particularly that of the 
voltage-gated calcium channel blockers, or ω-conotoxins (45). Analysis of ω-conotoxin MVIIA 
revealed an increased folding efficiency with the presence of the pre-PTM Glycine at the C-
terminus. This challenged the original concept that the larger N-terminal pre-pro sequence was 
the main source of thermodynamic favorability in enzyme-mediated folding and oxidation. C-
terminal amidation is also thought to contribute to the formation of native globular structures 
within the α-conotoxin family. This is specifically illustrated with α-conotoxin ImI (45). It has 
been shown that this conotoxin can be converted from a well-established nicotinic acetylcholine 
receptor (nAChR) antagonist to a newly defined noradrenaline receptor ligand through excision 
of the C-terminal amide. It is believed that the C-terminal amide strongly influences disulfide 
bond connectivity arrangement, causing major structural changes that in turn define biological 
function and selectivity. Structural studies using software modeling and NMR have revealed that 
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C-terminal amidation in α-conotoxin ImI disrupts the folding of the ribbon conformation, 
particularly when Proline is present within the first intercysteine loop (48). These characteristics 
seem to increase the probability of forming a globular structure in α-conotoxin ImI and also 
appear to be conserved in other toxins. The preponderance of this Proline/C-terminal amidation 
interaction among conotoxins suggests its efficacy in defining structural and biological 
properties.  
 
 In addition to C-terminal amidation, hydroxylation has also been reported as a major 
influential PTM in the oxidative folding of conotoxins. The hydroxylation of amino acids (ααs) 
is a commonly observed PTM within conotoxins and is known to generally affect Proline or 
Valine residues as well as one currently documented instance of a Lysine modification. There are 
approximately 86 known naturally occurring conotoxins containing both 4-cis- and 4-trans-
hydroxyprolines (Hyp/O) and 2 containing cis-hydroxy-D-Valine (49). Despite their abundance 
within conopeptides and conotoxin families, the precise contributions of these hydroxylated ααs 
to biological activity and structure are not completely understood. The hydroxylation of Proline 
in conopeptides has been shown to have various effects among different gene families. 4-Cis- 
and 4-trans-hydroxylated Prolines in P-conotoxin GIIIA were shown to increase the rate of 
inhibition of NaV1.4 sodium channels anywhere from 2.5 to 4.5 times, while having little effect 
on oxidative folding (50). In contrast, hydroxylation of α-conotoxins ImI and GI displayed a 
lower activity when Proline was substituted with Hyp, despite increased stability in their overall 
structures. 
 
The Hyp substitution in α-conotoxin ImI makes the conotoxin completely inactive against 
α7 nAChRs while substitution in α-conotoxin GI appears to have a greatly reduced affinity for its 
respective nAChRs (50). A similar structural improvement was found in ω-conotoxin MVIIC, 
which experienced an approximate two-fold yield increase in oxidative folding and retained 
biological activity. The appearance of Hyp in most forms of proteins and peptides is generally 
due to the presence of prolyl-4-hydrolase (EC 1.14.11.2) (51). Presently, prolyl-4-hydrolase 
within the venom glands of the Conus genus has not been reported. It may also be possible that 
the enzyme responsible for the hydroxylation of Proline has a broader specificity that includes an 
ability to hydroxylate Lysine, based on previous research involving Conus delessertii (52). The 
production of partially or mixed PTM variants are a common occurrence within Conus, (53,54). 
This feature may represent a mechanism to increase chemical diversity and influence biological 
spectrum of conotoxins. It has been shown that the folding of conopeptides containing more than 
one Hyp is assisted by a molecular chaperone enzyme known as peptidylprolyl cis–trans 
isomerase (EC 5.2.1.8) or PPI, which happens to be a subunit of prolyl-4-hydrolase, indicating 
that folding and hydroxylation may be a simultaneous or coupled process (55). Several isoforms 
of PPI have been isolated from Conus novaehollandiae including PPI B, an enzyme present in 
the snail’s ER, and two cytosolic forms. PPI B is known for its ability to isomerize trans-
hydroxyprolines to the cis conformation, which in turn may increase the stability of the peptide 
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structure. Structural stability via isomerization was observed by NMR in vitro by comparing μ-
conotoxin GIIIA that contained two trans Hyp, ω-conotoxin MVIIC that contains one Pro/Hyp 
residue and μ-conotoxin SIIIA that contained no Hyp residues. In this study, increased Conus 
PPIase caused a larger production of the native μ-conotoxin GIIIA while having little effect on 
the production of the non-hydroxyproline containing peptides. This provides evidence to the 
concept that the presence of Pro/Hyp gives rise to structural changes among conopeptides that 
can be facilitated by PPIases. 
 
1.1.4 Conotoxin Structure 
 
Conotoxins, despite their small size (~11-40 αα) often contain a certain degree of 
secondary structure that in addition to their cross-linked cysteine rich side chains, allows them to 
adopt highly stable folds. These secondary structures include but are not limited to alpha helices, 
which are almost ubiquitous in the aptly named α-conotoxins, and β-sheets which are often 
observed in F/O- and μ-conotoxins (Figure 3). These structural elements are sometimes held 
together in various turns such as β- or J-turns. Due to the presence of these secondary structures 
nearly all conotoxins are considered to form well-ordered structures. The exception to this case is 
the α-conotoxin BuIA, where the globular form that has a strong affinity for nAChRs, exists in at 
least three different conformations and does not appear to have a stable backbone (56).  
 
 
Figure 3: A comparison between the two prominent forms of secondary structure 
seen in conotoxins; an alpha helix as shown in α-MII (3) (left) and antiparallel β-
sheets as shown in F-MrIA (4) (right). Both structures were obtained from the 
World Wide Protein Databank (wwPDB) and were visualized using YASARA.  
 
Conotoxin primary sequence is generally highly variable however there are particular 
cysteine patterns that have been determined to be highly conserved (31,32). These patterns are 
known as “cysteine frameworks” and have been directly correlated to motif formation as well as 
pharmacological families. Cysteine frameworks deal directly with whether or not the cysteines 
are separated by other residues, the collective of which are known as loops. Cysteine framework 
I for example consists of a sequence XCCXCXC, where X is any residue or number of residues 
and C is cysteine. The intercysteine loop “size” or the amount of residues between each loop also 
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correlates directly to structure/activity, and the combination of a particular cysteine framework 
and loop size may provide a general insight to what pharmacological family a conotoxin belongs 
to. For example the conotoxins which contain two disulfide bonds and cysteine framework I all 
either belong to the α-, F-, or ρ-pharmacological families whereas the conotoxins which contain 
4/2 intercysteine loop sizes exclusively belong to the F-pharmacological family.  
 
In addition to secondary structure, motifs formed by conotoxins include globular type 
folds which are found in four cysteine containing peptides in which the disulfides encompass one 
another, i.e. C4-C12, C3-C9 where C is the one letter code for cysteine and the number is the 
position in the sequence, ribbon type folds in which the disulfides are flanking one another (C3-
C12, C4-C9), or a “beaded” fold in which the disulfides are completely vicinal (C3-C4, C9-C12) 
(Figure 4). Globular type folds are observed to be a commonplace motif for most of the smaller 
conotoxins including the α- and ρ-conotoxins, whereas the ribbon motif appears to be far more 
rarely observed with it only having been naturally observed in the F/O-conotoxins thus far 
(31,32).  Finally, the vicinal disulfide or “beaded” motif, although seen in other biologically 
relevant proteins such as thioredoxin (57), has yet to be observed as a natural occurrence in 
conotoxins.  
 
Figure 4: The three different possible disulfide configurations of a peptide 
containing four cysteines. PnID, the novel peptide described here is used as an 
example. 
 
 
Conotoxins containing three disulfides also appear to have prominent motifs, the most 
notably being the “inhibitor cysteine knot” motif, which is also commonplace among other 
peptide toxins and comprises approximately 40% of the known peptide toxin motifs (58).  
 
Conotoxin structure has largely been elucidated through the use of NMR solution-based 
studies, where over 90% of conotoxins have had their structures determined by NMR, which is 
in direct contrast to other proteins, where the majority of the entries in the Protein Databank 
(PDB) have been solved by X-ray crystallography (58). This difference is largely in part due to 
the convenience of studying small, water soluble peptides in solution through well-established 
methods rather than attempting a set of trial and error crystallization techniques. The drawback 
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however in using solution state NMR to study peptides is the possibility of missing important 
key elements which might cause a significant increase in activity, such as the binding of 
particular ions like calcium. Additionally X-ray crystallography holds a significant advantage in 
determining binding interactions or distortion/flexibility in structure that might be necessary for 
fitting a binding site (58). 
 
F-Conotoxins and topologies 
 
F (also known as O)-conotoxins, are known for their unique 4/2 inter-cysteine loop size, 
preferential formation of the ribbon disulfide connectivity (59,60), and their potent inhibition of 
the norepinephrine transporter or NET, a therapeutic target for severe cancer pain and epilepsy 
(61). Synthetic disulfide isomers of the F-conotoxin CmrVIA and the many vigorously studied α-
conotoxins have for the most part been significantly less active (a 10 fold reduction or more) 
than their native counterparts, enforcing the notion that the disulfides within these residues form 
critical crosslinks which stringently stabilize their active motifs (62,63). Exceptions to these 
observations however have been previously documented with some “non-native” connectivies 
displaying an even greater amount of activity than the “native” linkages observed in these 
peptides. One such example of this is the previously mentioned α-conotoxin AuIB in which the 
“non-native” ribbon isoform illustrated a 10-fold higher activity than the globular form (64). This 
phenomenon has also been reported in the P-conotoxin family where multiple isoforms of P-
KIIIA displayed low nM Kds (65), indicating that disulfide cross-links can hold multiple 
configurations without always significantly perturbing structure and activity. 
 
The determination of the native disulfide bond connectivity of peptide toxins is often a 
difficult process, (especially as the number of possible disulfides within a peptide increases) 
recurrently requiring large quantities of peptide and multiple experiments (66). In addition 
disulfide bond formation is a PTM and cannot be directly predicted on the genetic level. Due to 
these difficulties and the observation of increased activities of particular conotoxins with “non-
native” disulfide connectivities, it may be possible that Conus is capable of producing multiple 
native disulfide isomers as venom peptide constituents that until this point have gone 
undiscovered. 
 
1.2 Project Overview 
 
The goal of this project is to determine what unique structure activity relationships are 
associated with the “Chi-like” conopeptide PnID and if these properties could be applied to the 
development of future peptide based drugs. Preliminary data suggests that one of the disulfide 
bond isomers of PnID may contain a unique topology that is not detectable by current reduction 
and alkylation techniques or standard quality control processes. Currently one of the biggest 
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hurdles preventing cysteine rich peptides from transitioning to therapeutics is the issue of 
forming the most active structural motif in high enough yields to create a cost effective product. 
Of the hundreds of disulfide-bonded conotoxins discovered to date, much of the emphasis in 
achieving the “correct fold” has been placed on obtaining the appropriate disulfide connectivity.     
 Here a unique conopeptide is presented which contains interactions that influence its 
overall topology as well as its preferential disulfide connectivity. This peptide contains 
properties which if better understood could provide further insight as to the importance of 
disulfide and non-disulfide bond stabilizing characteristics within peptides. 
 
Here we investigate the unique folding properties of the conotoxin PnID, which was 
isolated from the Red Sea Conus pennaceus (Bingham and Wolfender, unpublished data) 
otherwise known as the “feather cone” and appears to be related to the pharmacological family 
of F/O-conotoxins or noradrenaline transporter inhibitors due to its sequence similarity to the 
originally discovered toxins within this family: MrIA, MrIB, and CmrVIA, both genetically and 
by mature sequence (67). Although the sequence of this peptide has been previously reported by 
genetic analysis (68-70) this is the first instance where protein level interactions, biological 
activity, and structural information have been investigated and to the best of our knowledge this 
is the first report not only of the existence of native disulfide isomers but also of topological 
isomers of the same toxin sequence and disulfide linkage existing within Conus.   
 
An investigation of topological isomers (isomeric material produced by geometrical 
shape and constraint independent of covalent bond connectivity or stereochemistry) in particular, 
helps to better characterize peptides that may be currently understudied. Topology is known to 
be an important factor in the regulation of DNA accessibility however very little research has 
been reported on the topology of conotoxins, as most of the research focus is exclusively on 
disulfide bond connectivity. An understanding of peptide topology would help to bolster the 
already growing biologics industry by providing accurate information on the desired products 
from synthesis and prevent inaccurate data from biological activity assays that may arise due to 
negligently assigning structure and activity from disulfide connectivity alone. 
 PnID is a unique 4/2 conopeptide that contains a high amount of homology to the χ-
conotoxins. Unlike the χ-conotoxins that contain a CCGYKLCXXC sequence (where X can be 
any known amino acid) PnID contains a CCGYRMCVPC stretch making it closely homologous 
but diverse from the known χ-conotoxins. Also apparent in the χ-conotoxins is the presence of a 
Valine before the first Cysteine and a hydroxyproline in the last inter-cysteine loop. These 
residues have been previously characterized by NMR to be involved in stabilizing hydrophobic 
interactions (4). It is believed that the lack of this interaction in the proper areas of the molecule 
might be a contributing factor to the absence of a single apparent isomer in the oxidation of 
PnID. 
Therefore the unique properties of PnID present potentially interesting characteristics and 
the study of these characteristics will contribute to our understanding of the effects of sequence 
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diversity in the 4/2 conotoxins, help us better understand the stabilizing factors for these inter-
cysteine loops, possibly broaden our understanding of selectivity in conotoxins, and provide 
further insight for the production of better drugs in the future.   
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1.3 Objectives and Hypothesis 
 
Objective 1: Production of the randomly folded isomers of PnID. This will be done through 
solid phase peptide synthesis, isolation of the disulfide-reduced material by RP-HPLC/UV, 
Oxidation of the thiols under 9 different air-oxidation conditions, and confirmation by mass 
spectrometry (MS).  
 
Rationale: Two native peptides of PnID were originally discovered as isomers in the same duct 
venom sample. To the best of our knowledge isomeric material of a peptide isolated from native 
Conus venom has never been seen elsewhere. It is therefore suspected that these native isomers 
have unique folding capabilities that are not possible in other venom peptides. 
 
Hypothesis: Random air-oxidation of the unfolded or “linear” PnID will produce maximally 
three isomers since it only contains two disulfide bonds, two of which will be the isomers seen in 
the native venom. 
 
Activities:  
 
1. The production of synthetic PnID through Solid Phase Peptide Synthesis (SPPS) 
2. Isolation of the product material through Reverse Phase High Pressure Liquid 
Chromatography (RP-HPLC/UV) and confirmation via Electrospray Ionization Mass 
Spectrometry (MS) (>97% purity). 
3. Non-selective (random) folding through oxidation of the thiol containing cysteines by 
introduction to a moderately basic environment in the presence of atmospheric oxygen 
for a period of 3-5 days.  
4. Characterization of the oxidation products by RP-HPLC/UV as well as confirmation and 
purity assessment of these products by ESI-MS 
 
Objective 2: Production of orthogonally protected PnID isomers through solid phase peptide 
synthesis and directed sequential oxidation. These will be co-eluted with the randomly folded 
material to determine the disulfide connectivity of each. Confirmation of their production will be 
assessed by ESI-MS, RP-HPLC/UV, and nuclear magnetic resonance spectroscopy (NMR).  
 
Rationale: Synthesis using differential protecting groups for two out of the four cysteines will 
allow the production of individual disulfide isomers. The selective folding should produce three 
possible forms including a ribbon, globular, and beaded form. The successive co-elution of each 
form by RP-HPLC/UV will provide evidence of which isomers are being produced. 
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Hypothesis: The Isomers produced by directed synthesis will co-elute with the three isomers 
produced by the random oxidation process indicating the presence of different disulfide 
connectivities. 
 
Activities:  
1. Production of the Ribbon (PnID isomer A), Globular (PnID isomer B), and Beaded forms 
(PnID isomer C) of PnID through SPPS, incorporating acetamidomethyl (Acm) 
protecting groups in addition to Trityl protecting groups on the cysteine side chains. 
2. Initial oxidation of the cleavage liberated thiols  
3.  Removal of the Acm groups, and the oxidation of the remaining disulfide 
4. Purification by RP-HPLC/UV and confirmation by ESI-MS 
5. Co-elution of each isomer with the randomly oxidized peptides. 
 
Objective 3: Production of the randomly folded isomers of the χ-conotoxins MrIA, and CMrIVA 
followed by comparative oxidations with the native PnID sequence. These isomers will be 
confirmed of their production by RP-HPLC/UV and MS. 
 
Rationale: Random oxidations of the PnID sequence fails to produce one apparent 
thermodynamic isomer. Comparative oxidations will be performed on the closely homologous χ-
conotoxins to determine if PnID is unique in the absence of this single thermodynamic isomer. 
 
Hypothesis:  Unlike PnID the χ-conotoxins will produce a single thermodynamic isomer. This 
difference is due to the critical placement of the Valine before the first inter-cysteine loop and 
it’s interaction with the Hydroxyproline in the last inter-cysteine loop, an attribute which is 
present in the χ-conotoxins but absent in PnID. 
 
Activities:  
1. The production of the randomly folded isomers of the χ-conotoxin MrIA by 
SPPS 
2. The production of the randomly folded isomers of the χ-conotoxin CMrVIA by 
SPPS  
3. Isolation of the product material through RP-HPLC/UV and confirmation via 
ESI-MS 
4. Non-selective (random) folding through oxidation of the thiol containing 
cysteines of each peptide by introduction to a moderately basic, organic, and 
chaotrophic environment (Urea 6M, NH4HCO3 100 mM pH 7.8 50% (v/v) 
propanol)  Each condition is outlined in the table below (Table 1). 
5. Characterization by RP-HPLC/UV and further Isolation of each isomer by RP-
HPLC and product confirmation by ESI-MS 
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Table 1:  Experimental oxidation conditions 
 
 Oxidation Agents Temperature Time 
Condition 1 0.1 M NH4HCO3 
pH 8 
 
25oC 3 days 
Condition 2 0.33 M NH4OAc 
0.5 GnHCl 
pH 7.5 
 
25oC 3 days 
Condition 3 2 M urea 
0.1 M NaCl 
0.1 M Glycine 
50% Propanol 
pH 7.8 
 
25oC 3 days 
Condition 4 0.1 M NH4HCO3 
pH 8 
 
4oC 5 days 
Condition 5 0.33 M NH4OAc 
0.5 GnHCl 
pH 7.5 
 
4oC 5 days 
Condition 6 0.33 M NH4OAc 
0.5 GnHCl 
pH 7.5 
50% Propanol 
 
4oC 5 days 
Condition 7 2M Urea 
0.1 M NaCl 
0.1 Glycine 
pH 7.8 
 
4oC 5 days 
Condition 8 2M urea 
0.1 M NaCl 
0.1 Glycine 
pH 7.8 
50% Propanol 
 
4oC 5 days 
Condition 9 6M urea  
50% propanol  
0.1M NH4HCO3 
pH 7.5 
4oC 5 days 
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Objective 4: LD50 Assays on the PnID isomers to determine differences in activity. PnID will be 
subjected to both fish and mollusk based assays. Additionally microgram-milligram quantities of 
each peptide (>90% purity) will be produced for their individual ion channel activity 
determination by whole cell patch clamp. PnID will be tested on: a norepinephrine uptake assay, 
GIRK1/4, GIRK1/2 and various nACHRs. 
 
Rationale: The biological activity of the PnID isomers must be determined on mollusks in 
addition to the fish due to its possible inherent phyla selectivity. Since there is little known about 
mollusk ion channels it is very difficult to perform patch clamp on them, it was therefore 
determined that LD50 assays on snails and fish in addition to a large scale screening of individual 
ion channels would be the most appropriate approach for characterizing biological activity. The 
determination of activity differences among the isomers for both of the peptides will allow us 
greater insight as to whether certain isomers may be better drugs, probes or pesticides. 
 
Hypothesis: At least two isomers from PnID will produce LD50s in the nMol/g range and/or 
nMolar potency on individual channels.  
 
Activities:  
1. Production of milligram quantities of PnID 
2. LD50 Assays on guppies with the individual PnID isomers 
3. LD50 Assays on cowries with the individual PnID isomers 
4. LD50 Assays on guppies with the mixed randomly oxidized PnID material 
5. LD50 Assays on cowries with the mixed randomly oxidized PnID material 
6. EC50 assays on the norepinephrine uptake assay using the two Globular and one 
Ribbon PnID isomers 
 
Objective 5: 2D NMR analysis on the major isomers of PnID in order to characterize their 
differences in tertiary structure. Correlation, total correlation, rotational overhouser, and nuclear 
overhouser experiments will be used to gather data on tertiary structure. Additionally this data 
will be used to generate restraints using the SPARKY program for the MD package YASARA 
Structure to model the most likely tertiary structures occurring in solution. All structures will be 
assessed using Ramachandran analysis. 
 
Rationale: Two-dimensional NMR analysis will provide conclusive evidence of the differences 
in tertiary structure among the directed isomers and the randomly folded isomers and provide 
insight as to why these unique differences are necessary for the enhancement of the activity of 
these peptides in their prey. NMR structure determination on a largely homologous peptide 
known as MrIA produced a stable structure that included two-disulfide stabilized beta sheets. 
Comparative analysis with PnID will provide insight as what might be causing the isomeric 
material. 
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Hypothesis: The directed isomers will contain different tertiary structures to that of the 
randomly oxidized isomers due to conformational differences among the peptides, despite 
containing the same disulfide connectivity. 
 
Activities:  
1. One dimensional NMR experiments on the Ribbon and two Globular PnID isomers 
2. Two dimensional COSY NMR experiments on the two Globular PnID isomers 
3. Two dimensional TOCSY NMR experiments on the two Globular PnID isomers 
4. Two dimensional NOESY NMR experiments on the two Globular PnID isomers 
5. Assignment of spin systems using the crosspeaks from j-coupled protons in the program 
SPARKY 
6.  Assignment of crosspeaks from dipolar couplings using the program SPARKY for each 
isomer 
7. Generation of a list of distance restraints from integrated and assigned peaks for each 
isomer 
8. Energy minimization of an extended structure of each isomer using a simulated annealing 
protocol and unambiguous restraints 
9. Refinement of the structures by removing errors, adding ambiguous restraints, and 
decreasing NOE energy 
10. Structure validation through the Protein Databank (PDB) and the Biomagnetic Resonance 
Bank (BMRB) 
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Chapter 2: Synthetic Production of PnID 
2.0 Introduction 
 
SPPS is often considered the preferred method for the production of conotoxins due to 
their short size, ease of implementing PTMs, and automation. Peptides have been synthesized 
chemically for over a half century, as the first synthesis of a bioactive peptide was done in 1953 
in the liquid phase by Vincent du Vigneud in which he synthesized the octapeptide oxytocin 
(71). A decade later Bruce Merrifield developed a simplified technique in which peptides could 
be synthesized in the solid phase by a cyclic process, allowing for the removal of waste by flow 
washing resin bound reactants in a scinted vessel (72). This technique paved the way for the 
automation of peptide synthesis and both men went on to win the Nobel Prize in chemistry. 
 
Modern SPPS may either be performed manually or automatically by a computerized 
synthesizer (73). Automated synthesis is often used when producing many peptides such as in 
combinatorial libraries, alanine scans, or large scale production whereas manual synthesis may 
be considered more ideal when creating test peptides, especially when the use of several solvents 
might be required, such as in the case of difficult couplings (74). SPPS is carried out using a 
solid resin support to which a chemical linker is added. This linker then contains a functional 
group with which the C-terminus of an amino acid (whose N-terminus and side chain are 
chemically protected) may be reacted or “coupled” using a derivatizing reagent. After coupling 
the resin is washed and the added amino acid’s N-terminal protecting group is removed and 
washed. This process is then repeated in cycles until the sequence is completed. The sequence is 
then cleaved from its solid resin support using a strong acid. The two major N-terminal 
protecting strategies for SPPS are Fluorenylmethyloxycarbonyl or Fmoc and tert-
Butyloxycarbonyl or t-Boc (75).  
 
The first conotoxins to be synthesized by SPPS were α-conotoxins GI and MI in the 
1980s (76). Before this conotoxins were obtained solely by isolation from native sources such as 
from the venom duct of the producing organism or later by “milking”, a strategy which includes 
manipulating the animal into having an ejaculation event and collecting the ejaculated venom. 
The practice of harvesting native venom, although highly beneficial for the discovery of new 
peptides, is considered to be a less sustainable practice than chemical synthesis as it requires the 
organism to be removed from its natural environment and in the case of venom duct extraction 
even requires the animal to be sacrificed.  
 
In addition to SPPS some conotoxins are produced through expression in a single celled 
organism such as E. coli. The technology of recombinant DNA expression did not become 
available until the 1980s (77) and the first conotoxins to be synthesized recombinantly were only 
produced recently (78). Although recombinant production of conotoxins might be considered a 
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cheaper process once an efficient method is developed, the relative difficulty involved in method 
development and the need to tailor each expression system to an individual peptide sequence has 
made it a far less attractive method in comparison to SPPS as of yet. In addition, the major 
disincentive is the inability, at present, to undertake site-specific PTM incorporation (including 
unnatural amino acid analogs), an essential structural/pharmacological character within many 
conotoxins. 
 
PnID, like many conotoxins is a very short peptide and consists of only 12 amino acids. 
The sequence of PnID (Table 2) contains only a C-terminal amide and two cystine linkages as 
PTMs. These characteristics make PnID an ideal candidate to be produced by SPPS as the 
synthesis can be undertaken very quickly and the orthogonal protecting strategy can be 
developed to regio-selectively form disulfide bonds. 
 
Table 2: Comparison between the mature regions, activity and folding of the reported F-
conotoxins 
 
F-conotoxin Mature sequence Superfamily Framework EC50 NET Connectivity Ref 
PnID STCCGYRMCVPC-NH2 T X 10 µM 1-4, 2-3 this work 
MrIA NGVCCGYKLCHOC T X 645 nM 1-4, 2-3 (67,79,80) 
MrIB VGVCCGYKLCHOC T X 860 nM 1-4, 2-3 (67) 
CmrVIA VCCGYKLCHOC T X N/A 1-4, 2-3 (81) 
  
O = 4-trans-hydroxyproline;NET = Norepinephrine Transport uptake assay 
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2.0 Materials and Methods 
2.0.1 Manual Solid Phase Peptide Synthesis (General) 
 
Swelling of the Resin: 
 
0.5 Mmoles of Methylbenzylhydroxyamine (MBHA) resin containing a rink amide linker 
(0.44 meq/g loading) was measured and poured into a reaction vessel. 10-20 mL of 
Dimethylformamide (DMF) was added to the reaction vessel and allowed to shake for 10 
minutes. The DMF was drained and 20 mL of fresh DMF was added to the reaction vessel. The 
resin was allowed to swell overnight, or for a minimum of 8 hours. 
 
Activation of Fmoc Amino Acids: 
 
The desired amino acid of choice was measured to 2 mMoles and placed in a scintillation 
vial. In a separate scintillation vial 2 mMoles of 2-(6-chloro-1-H-benzotriazole-1-yl)-1,1,3,3-
tetramethylaminium hexafluorophosphate (HCTU) was weighed. The HCTU was dissolved in 4 
mL of DMF and the solution was transferred to the scintillation vial containing the amino acid. 
347 μL of DIEA was added to the reaction vessel to quench the protons generated during amino 
acid activation. If it appeared that the desired Fmoc amino acid was not fully dissolved, the 
scintillation vial was sonicated to ensure that the amino acid and coupling reagents were in 
solution. The amino acid and activating reagents were measured in 4-fold excess to the 0.5 mMol 
resin, resulting in 2 mMoles. 
 
Amino acid Coupling: 
  2 mMoles of the activated amino acid was added to the reaction vessel containing 0.5 
mMol resin and allowed to couple for 10-20 min. Since the amino acid is in 4-fold excess to the 
potential binding sites on the resin the reaction is expected to reach theoretical completion. The 
reaction was considered complete when the % coupling as determined by ninhydrin test 
exceeded 99.5%. 
 
2.0.2 Ninhydrin Analysis: 
Procedure: 
 
Ninhydrin analysis was undertaken to determine if the coupling % of amino acid was 
satisfactory and the next amino acid in the primary sequence could be added to the growing 
peptide chain (82).  2 to 5 mg of the peptide resin was removed from the reaction vessel and flow 
washed with 50% v/v DCM in Methanol on a filter thimble under vacuum until the peptide resin 
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was dry. The resin was then transferred to a tared tube and the mass was recorded. The following 
reagents were added to the test tube containing the peptide and an empty control tube: 2 drops of 
76% w/w phenol in ethanol, 4 drops of 0.2 mM potassium cyanide KCN in pyridine, and 2 drops 
of Reagent 0.28 M ninhydrin in ethanol.  Both the tubes were covered with Parafilm® and placed 
in a sand bath, regulated at 110º C for 5 min. After removal from the sand bath, 3 mLs of 60% 
ethanol in water (v/v) was added to each test tube and centrifuged for 30 seconds. The 
supernatant was collected and absorbance of the resin sample was read against the control blank 
at 570 nm and recorded. 
 
Calculation of Percent Coupling: 
  
Percent coupling can be calculated with the following equation  
 
𝑃𝑒𝑟𝑐𝑒𝑛𝑡 𝐶𝑜𝑢𝑝𝑙𝑖𝑛𝑔 = 1 − ൬
𝑁𝑉
𝑆𝑉 ൰ ∗ 100 
 
The term NV stands for Ninhyndrin Value and provides an estimate for the free unreacted 
amines that did not bind to the previous amino acid during the coupling step. NV can be 
calculated using the following equation.  
 
𝑁𝑉 =
(𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒570)(200)
𝑟𝑒𝑠𝑖𝑛 𝑚𝑎𝑠𝑠 (𝑚𝑔)  
 
The SV or Substitution value provides the theoretical mole value of the total peptide. SV 
is calculated using the equation below. 
 
                   New SV = (previous SV)/ [1 + (previous SV x AA MW)] 
 
The previous SV for the first amino acid was determined through the Resin loading 
Value, which was provided by the manufacture. This value indicates the number of moles/g of 
resin. While calculating the amino acid molecular weight N-terminal and orthogonal protecting 
groups were considered. 
Substituting observed data into the % coupling equation provided the % coupling. If this 
value was greater than or equal to 99.5% the next amino acid was coupled to the growing peptide 
chain. A score of below 99.5% indicates that the coupling did not reach the desired level of 
completion.  
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2.1.3 End Capping: 
 
If the sequence repeatedly fails to reach 99.5% coupling, usually due to aggregation of 
the peptide chain or by steric hindrance, end capping becomes a necessary option. Free amino 
functions cause a deletion product when the new amino acid is coupled to the growing peptide 
chain that is permanent and leads to side products that reduce the final yield of target peptide and 
may cause difficulty during peptide purification. In order to prevent this from happening the free 
amino groups are capped with an inert moiety that prevents the N-terminal functionality from 
reacting during the rest of the synthesis. 
To End cap the free amino termini, the resin was first flow washed with an abundant 
amount of DMF to remove any former unreacted amino acids and reagents from the system. 50% 
v/v N-methylpyrrolidone (NMP) in DCM was flow washed through the resin twice using ~20 
mL each time. While doing this step extreme caution must be undertaken to avoid letting air pass 
through and dry the resin in order prevent oxidation of susceptible residues such as Methionine 
or Histidine.  The reagent N-(2-chlorobenzyloxycarbonyloxy) succinimide (Z[2-Cl]-OSu) was 
weighed out in a scintillation vial to 0.5 mMol and dissolved in 4 mL of the NMP/DCM solvent 
previously prepared to activate the Z(2-Cl)-OSu. 347 µL of DIEA was added to the scintillation 
vial, mixed, and poured into the reaction vessel and allowed to react for 5 min.  The reagents 
were then removed by two flow washes of approximately 20 mL using the NMP/DCM solvent, 
and then using abundant DMF. Upon completion all free Nα-terminal groups of the peptidyl-resin 
were terminated. 
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2.1.4 Synthesis of PnID random, A, B and C and the “Reverse” isomers 
 
The PnID isomers were all synthesized using the previously mentioned solid phase 
peptide synthesis (SPPS) protocol (see Section 2.1 of methods). PnID A, B, and C all contained 
the primary sequence STCCGYRMCVPC-NH2 and were all synthesized using the side chain 
protecting groups: Ser(tBu), Thr(tBu), Cys(Trt), Arg(Pbf), and Tyr(tBu), with the addition of 
Cys(Acm) on positions 3 and 12 on isomer A, positions 3 and 9 on isomer B, positions 9 and 12 
on isomer C, positions 4 and 9 on isomer RevA, and positions 4 and 12 on isomer RevB (Table 
3).  Another PnID isomer which was just referred to as PnID, or PnID random was synthesized 
using Cys(Trt) for all cysteine residues. Upon completion of synthesis, the peptidyl-resin was 
washed with DMF (2x, 5 mL) followed by Dichloromethane (DCM; 10 mL) and dried under N2.  
 
Table 3: PnID Isomers that were produced by regio-selective synthesis (using Acm and Trityl 
orthogonal protecting groups) and oxidative folding. The numbers on the disulfide bonds 
indicate the order in which they were selectively formed. 
Name Connectivity 
PnID A (PnID II) 
(RevA) 
 
 
 
Ribbon 
PnID B (PnID I)  
 
 
Globular 3-9, 4-12 
PnID RevB  
 
 
Globular 4-12, 3-9 
PnID C  
 
 
Beaded 
 
2.1.5 Synthesis of MrIA-amidated and CmrVIA-amidated 
 
MrIA-NH2 and CmrVIA-NH2 were both synthesized using the previously mentioned 
SPPS protocol (see Section 2.1 of methods). MrIA amidated has the primary sequence 
NGVCCGYKLCHOC-NH2 and was made using the orthogonal protecting groups: Asn(Trt), 
1 
1 
2 
 2   
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Cys(Trt), Tyr(tBu), Lys(Boc), His(Trt), and Hyp. CmrVIA amidated has the primary sequence 
VCCGYKLCHOC-NH2 and was made using the same respective orthogonal protecting groups 
as MrIA-NH2. 
2.1.7 Cleavage from resin and oxidative Folding 
 
Assembled peptides were cleaved using Reagent K [TFA (82.5% v/v), phenol (5% v/v), 
water (5% v/v), thioanisole (5% v/v), and triisopropylsilane (TIPS) (2.5% v/v)]. 40 mL of 
Reagent K per gram of peptidyl-resin was mixed for 2 h at 24 °C. Cleaved slurry was vacuum 
filtered into liquid N2 chilled tert-butyl methyl ether. Peptide precipitate was pelleted by 
centrifugation (3000 g, 10 min) and washed twice with chilled tert-butyl methyl ether. The 
resulting peptide pellet was suspended in 25% v/v acetic acid, then freeze-dried to form a powder 
and stored at −20 °C until required. Crude peptides (1 mg mL−1) were oxidized using 100 mM 
NH4HCO3 pH 8 and stirred for 5 days at 4 °C. Oxidized material was filtered (0.45 μm) prior to 
semi-preparative RP-HPLC/UV fractionation. Cleaved F-conotoxins PnID A, B, C, RevA, and 
RevB were RP-HPLC/UV purified, and then air oxidized, as above. Partially oxidized materials, 
as confirmed by ESI-MS, were then subjected to spontaneous thiol deprotection and disulfide 
bond formation. Deprotection was achieved by dissolving the partially folded peptide in 50% 
v/v acetic acid (1 mg mL−1) and by adding a solution of freshly saturated I2 in 50% v/v acetic 
acid to the stirring peptide (25% reaction vol.). Reaction was quenched after 5 min with the 
addition of 10 μL aliquots of 1 M Na2S2O3 until the stirring solution became clear, which was 
then followed by the addition of 200 μL 0.1 % TFA. Resulting acidified material was centrifuged 
(12,000 × g, 5 min) and directly purified by preparative RP-HPLC/UV (as above) with mass 
confirmation provided by ESI-MS. 
 
2.1.8 RP-HPLC/UV and Co-elution Experiments 
 
Native and synthetic conotoxins were individually separated as follows: (i) Capillary Scale 
(Phenomenex; C18, 5 μm, 300 Å, 1.0 × 250 mm, flow 100 μL min−1) - used for comparative RP-
HPLC/UV profiling, to control the quality of peptide purity, to quantify the peptides and to 
perform peptide co-elution experiments. (ii) Analytical Scale (Vydac; C18, 5 μm, 300 Å, 
4.2 × 250 mm, flow 1 mL min−1) - used for the isolation and purification of native peptides for 
ESI-MS. (iii) Preparative Scale (Vydac; C18, 10 μm, 300 Å, 22 × 250 mm, flow 5 mL min−1) -
used for the preparative separation of crude synthetic peptides for co-elution experiments, 
structure determination, and pharmacological assays. Systems (i) and (ii) used a Waters 2695 
Alliance RP-HPLC System interfaced with a 996 Waters Photo Diode Array Detector for 
automated sample analysis and detection. Data was acquired and analyzed using Waters 
Millennium32 (v3.2) software. Samples were eluted using a linear 1% min−1 gradient of organic 
(90/10% v/v CH3CN/0.08% v/v aq. TFA) Solvent B against aqueous (0.1% v/v TFA aq.) Solvent 
A for 65 min, excluding a terminating high organic wash (80% Solvent B for 5 min), and pre-
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equilibration step (5% Solvent B) for 10 min prior to sample injection. Eluent was monitored 
from 200–300 nm and extracted at 214 nm. Preparative RP-HPLC/UV, system (iii), used a 625 
Waters HPLC pump and controller interfaced with a 996 Waters Photo Diode Array Detector. 
Both gradient control and data acquisition were facilitated by the use of the Waters 
Millennium32 software. Filtered (Nylon 0.22 μm) synthetic peptides and crude DV peptide 
extracts were manually loaded and eluted from the preparative scale column using the same 1% 
gradient at 5 mL min−1 and monitored at 214 and 280 nm. Fractions were collected manually and 
stored at −20 °C or freeze-dried until required. Each of the peptide isomers as well as the 
products from air oxidation were co-eluted both in 1:1 and 2:1 ratios on a C18 capillary-bore RP-
HPLC/UV (Phenomenex; 5 μm, 300 Å, 1.0 × 250 mm) column. 
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2.2 Results  
2.2.8 Synthesis Products 
 
Each synthesis resulted in the production of peptide with the expected mass (Figure 7 is 
representative, for all spectrographs see Appendix B). Minor products were seen in each 
associated RP-HPLC/UV chromatogram and mass spectra, however in every case the target 
material was the dominant peak. Each resulting peptide was brought to a purity of ~> 95% 
before being used for other experiments or assays (Figures 5 and 6 are representative, for all 
chromatograms see Appendix A).  
 
 
Figure 5: RP-HPLC/UV chromatogram of crude PnID A containing two 
orthogonally protected Acm cysteines and two cysteines with free thiols. 
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Figure 6: RP-HPLC/UV chromatogram of the fully folded and purified form of 
PnID A. 
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Figure 7: Mass spectrograph of the fully folded PnID A containing no orthogonal 
protecting groups. 660.3 was the observed mass to charge ratio (m/z) in the 
second charge state. The expected m/z was 660 +/- 0.5 [M+2H]+2. 
 
2.2.9 RP-HPLC/UV Co-elution 
 
In peptides containing 4 cysteines, three specific disulfide pairings known as ribbon, 
globular, and “beads on a string” or beaded forms, are hypothetically achievable. Figure 8 shows 
the HPLC/UV chromatograms of the individual and mixed isomers of PnID that were previously 
subjected to oxidative folding. Co-elution was attempted between the products oxidized by a 
two-step folding process and those formed by a single step air oxidation in order to determine 
what disulfide bridges were susceptible to formation, as not each of the three possibilities will 
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always occur due to energetic barriers such as steric hindrance, torsional strain, or charge 
repulsion. The experiments were carried out both with the isomers at equal concentration (not 
shown), and at roughly 1:2 concentrations (peptides produced by a single step oxidation and a 
two-step oxidation respectively). PnID A, B, C, RevA, and RevB were all folded via two-step 
processes, allowing for the control of particular disulfides to be formed in a pre-determined order 
(see methods). PnID A, which contained disulfide bonds between cysteines 3-12 and 4-9 (ribbon 
isoform) was observed to co-elute with the more hydrophobic peak in the air oxidation profile, 
displaying one sharp peak without evidence of shouldering. PnID B, that contained disulfide 
bonds between cysteines 3-9 and 4-12 (globular isoform) did not appear to co-elute with any of 
the isomers produced within the air oxidation profile, exhibiting distinct shouldering with the 
earlier eluting major peak. PnID C, which contained disulfide bonds between cysteines 3-4 and 
9-12 (beaded isoform) also did not appear to co-elute with any of the peaks generated from the 
air oxidation.  
 
 
 
Figure 8: RP-HPLC/UV chromatograms of the isomers of PnID. 2A shows the 
products of the pre-purified air oxidation, 2B shows the attempted co-elution of 
PnID A with the air oxidation products, 2C shows the attempted co-elution of 
PnID B with the air oxidation products, 2D shows the attempted co-elution of 
PnID C with the air oxidation products, 2E shows the attempted co-elution of 
PnID RevA with the air oxidation products, and 2F shows the attempted co-
elution of PnID RevB with the air oxidation products. * indicates position of the 
mixed peak. 1. indicates which disulfide was formed first. 
 
In order to determine if the earlier eluting major peak in the air oxidation chromatogram 
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was the results of a particular topology and not necessarily disulfide connectivity, the positions 
of the acetamidomethyl (Acm) and trityl orthogonal protecting groups of the PnID A isomer 
were reversed and resulted in the production of PnID RevA (see methods), which also co-eluted 
with the most hydrophobic peak in the air oxidation chromatogram and resulted in no distinct 
separation or shouldering, indicating that the order of disulfide bond formation was 
inconsequential to topology in this case. The positions of the Acm and trityl orthogonal 
protecting groups of the PnID B isomer were then reversed and resulted in the production of 
PnID RevB, which unlike the PnID B isoform, appeared to completely co-elute with the major 
peak in the air oxidation chromatogram with the earlier retention time and displaying no distinct 
separation or shouldering. In order to confirm the difference in retention time by the PnID B and 
PnID RevB isomers, the two globular isomers were mixed at approximately equal and 1:2 
concentrations. The resulting chromatograms (Supplemental Figure 1.) show distinct shouldering 
between the two globular isoforms.  
 
2.3 Discussion 
 
A comparison of the retention times of the synthetic oxidation carried out by air oxidation 
to that of the native isomers (previous work) indicates that the larger constituent of the native 
isomers is likely cross-linked in a globular fashion, as it is the less hydrophobic of the two 
isomers. This finding is novel as every F/O-conotoxin discovered to date has claimed a ribbon 
connectivity and synthetic isomerization to the globular form has resulted in a significant loss of 
activity (59,60). Additionally PnID contains a native C-terminal amide, a PTM which has been 
previously observed in the similar conotoxins O-CmrVIA P6 amide (synthetic) and α-conotoxin 
ImI to be a significant contributing factor to the preferential formation of a globular disulfide 
connectivity (62) and likely participating in a switch mechanism for favorability between 
disulfide configurations. C-terminal amidation, although never before determined to be present 
in previously discovered F-conotoxins, has been synthetically added to MrIA-NH2 and was 
determined to slightly increase binding capacity to the NET (67). Therefore it is likely that the 
amidation of PnID holds a role that is two-fold, not only aiding in the formation of a globular 
isomer but also providing a stronger peptide-receptor interaction. Before PnID, globular forms of 
F-conotoxins have not been found to have any significance and were considered to be the result 
of misfolding.  
 
Further comparison between the primary sequence of PnID and that of other F-
conotoxins reveals that significant differences occur in the second and before the first inter-
cysteine loops (Table 2). All currently known F-conotoxins contain a Valine before the first 
cysteine in the sequence and a 4-trans-hydroxyproline and Histidine in the final inter-cysteine 
loop. This common characteristic was investigated with respect to the integrity of F-MrIA’s 
structure activity relationships (4). After performing alanine scans it was determined that Valine 
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3 and 4-trans-hydroxyproline 12 are critical residues for maintaining stability in F-MrIA. 
Additionally NMR analysis provided insight to hydrophobic interactions that occur between 
these residues. Thus it is likely that the unique placement of Valine and Proline in PnID might 
aid in its lack of preference for a particular connectivity or provides a slight preference for a 
globular connection. 
 
The slight shouldering of PnID B when undergoing co-elution experiments with the air 
oxidized material indicates that the two globular peptides, PnID B and PnID RevB are similar in 
hydrophobicity and thus likely similar in structure. It may therefore be possible that other 
globular peptides who exhibit broad peaks upon subjection to air oxidation are not producing a 
single isomer, but that of two topologies. Therefore it is recommended that if a broad peak 
results from an air oxidation, that a regio-selective synthesis be undertaken for comparison. If a 
peptide produces a sharp peak after a regio-selective oxidation but a broad one after air oxidation 
it is likely that other isomers, possibly topological, may be present. 
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Chapter 3: Comparative Folding of PnID and Related  
F-Conotoxins 
 
3.0 Introduction 
 
As previously alluded to in chapters 1 and 2, F-conotoxins are unique due to their 
XCCGYKLCXOC sequence (where X is any amino acid), preference for folding in a ribbon 
fashion (C1 paired with C4 and C2 with C3) and their selective inhibition of the NET (67). 
Unlike the α-conotoxins that are considerably well studied, the F-conotoxin family consists of 
only a handful of peptides which have undergone in depth investigation, despite that other 
genetic and peptide sequences are known which may be of the F-conotoxin family (31,32). As 
with the study of many of the previously discovered conotoxins the main focus of the studies 
done on the established F-conotoxins has been: to determine the peptide sequence, discover what 
type of biological activity the toxin confers, to isolate a selective pharmacological target, to 
determine what type of tertiary structure the peptide has, and finally to determine what degree of 
stability is associated with that structure. The purpose of this section is to bridge the gap between 
the unique sequence and folding behavior of PnID with that of the already known F-conotoxins 
and mine this information to further our understanding of why particular peptides and motifs fold 
more efficiently than others.  
 
The first F-conotoxin discoveries were made in the year 2000 and were reported 
simultaneously by Balaji et al. and McIntosh et al. (79,81). Although the sequences, cysteine 
pairing preference, and biological activity in whole animals were reported by both groups, the 
molecular target was not elucidated until a year later by Sharpe et al. (67), thus Balaji and 
colleagues initially named this pharmacological class of peptides O-conotoxins indicating that 
they exhibited potent therapeutic potential as a symptom of injection despite not knowing the 
actual molecular target of these peptides. Sharpe and colleagues initially tested the F-conotoxins 
MrIA and MrIB isolated from Conus marmoreous, with a tensor assay on a rat vas deferens 
which resulted in activity indicative of inhibition of the norepinephrine transporter and later 
tested the peptides directly on that molecular target using various radio-ligand binding assays 
(67,80) and thus the F-conotoxin class was finally elucidated. 
 
As previously mentioned, F-conotoxins are not only unique due to their activity but also 
due to their respective folding preferences. Interestingly the F-conotoxins have highly similar 
sequences to one another and do not vary too far from the α-conotoxin frameworks. Of particular 
note is the cysteine framework of the α-conotoxin ImI, which contains a single additional amino 
acid in the second inter-cysteine loop of the peptide in comparison to that of the F-conotoxin 
framework (48). As referred to briefly in Chapter 1, the study conducted by Kang et al. took a 
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deeper look into the differences in folding among the highly similar disulfide frameworks of α-
ImI and F-CMrVIA in an attempt to flesh out how the disparity in these sequences contributes to 
either the iconic globular α-conotoxin fold or the more recently discovered ribbon preference 
adopted by the F-conotoxins. The work undertaken by this group resulted in several important 
discoveries relating to the preference of each fold: first, it was determined that the placement of a 
Proline within the first inter-cysteine loop of a conotoxin sequence contributes largely to a 
preferential globular fold, and second it was also determined that C-terminal amidation plays 
another significant role in shifting preference towards a globular motif. These observations were 
elucidated through several key experiments and observations within previous literature on both 
families of conotoxins. These experiments included the swapping of the first proline residue in α-
ImI with the corresponding lysine residue in F-CMrVIA and synthesizing C-terminally amidated 
as well as free acid variants of each peptide. The resulting products from each synthesis were 
then air oxidized and run comparatively by RP-HPLC/UV to regio-selectively synthesized 
variants in order to pinpoint the folding preference of the air oxidized peptides. Although the 
results of this study are highly significant in determining the importance of the Proline residue 
position and C-terminal modification with respect to in vitro (and probably in vivo) folding 
inclinations, they fail to bring to light the possibility of backbone topology changes in each 
isomer. The missing link with this and many previous experiments is that comparative RP-
HPLC/UV does not necessarily clarify slight changes in structure that may be produced through 
synthetically changing the order of disulfide formation within the conotoxin. Therefore it must 
be stressed in the future that regio-selectively synthesized products must be subject to co-elution 
and not simply comparative RP-HPLC/UV.  
 
All of the currently observed F-conotoxin folding preferences have so far been studied on 
an individual case by case basis and have until now proven that there is a strong preference for 
the ribbon fold within either the venom duct or the milked venom (79,81). Previous work 
however has shown that PnID, despite having a F-conotoxin like sequence does not follow this 
trend as it appears in two forms after disulfide bond formation within the venom duct.  Synthetic 
folding comparisons of each peptide to one another however have not yet been attempted. Since 
each conotoxin contains the same cysteine framework but slight sequence variations, differences 
in N-terminal truncation, and importantly the inclusion of a C-terminal modification or a free 
acid (PnID is the only observed F-like conotoxin to contain an amidated C-terminus thus far), 
comparative folding of PnID to that of the established F-conotoxins provides unique insight into 
folding preference and could provide further knowledge on possible F-conotoxin motifs to the 
established literature. In order to effectively compare the folding preference of PnID to that of 
the other F-conotoxins, C-terminally amidated forms of each conotoxin was folded by 
introduction to a moderately basic, organic, and chaotrophic environments and variables such as 
time and temperature were modified to study their effects on the folding patterns of each peptide. 
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3.1 Methods 
3.1.1 Oxidative folding conditions 
 
Each peptide was synthetically designed to contain orthogonal protecting groups that 
were removed upon exposure to the cleavage cocktail (see Chapter 2 methods) that ensured that 
free thiols would be available upon lyophilization and introduction to an in vitro oxidation 
buffer. Before undergoing folding, each peptide was >95% pure as assessed by RP-HPLC/UV. In 
vitro oxidative folding of peptides can occur by multiple pathways involving electrostatic 
interactions, hydrogen bonding, hydrophobic interactions, and minimization of steric hindrance, 
none of which ubiquitously take precedent in every peptide (39). Thus folding must be handled 
on case-by-case basis. In order to shed light on specific interactions occurring during the 
oxidative folding process each peptide was subjected to oxidative folding buffers with various 
conditions including changes in pH, temperature, hydrophobicity, ion pairing, and time. Table 1 
(see Chapter 1) illustrates the various conditions for each buffer. PnID was also folded in a 0.1M 
ammonium bicarbonate buffer (pH 7.8) for time intervals spanning 24 hours to 96 hours in an 
attempt to elucidate which isomer would be preferred kinetically and which would be the 
thermodynamic isomer.  
 
All three peptides were subjected to additional oxidative folding for 3 hours in a 0.1M 
ammonium bicarbonate buffer (pH 7.8) with glutathione oxidized/reduced (GSSG/GSH) at a 
ratio of 1:2 respectively in order to simulate in vivo folding conditions within the endoplasmic 
reticulum. Each peptide was then additionally folded for 24 hours under the same conditions to 
determine if equilibrium had been reached.  
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3.2 Results 
3.2.1 Folding properties of PnID 
 
Six out of nine oxidation conditions displayed a preference for the latest eluting isomer of 
PnID, which was previously determined to be the ribbon isoform (see Chapter 2) whereas 
conditions 1, 3, and 4 appeared to result in the favoring of the earlier eluting globular isoform 
(Figure 9). Conditions 1 and 4 only differ in the amount of time provided for oxidation to occur 
whereas condition 3 included a more hydrophobic environment, a mild chaotrope, and a change 
in ion pairing albeit for the same incubation period as conditions 1 and 4. The information gained 
from this experiment appeared to suggest that the addition of strong chaotropes interfere with the 
formation of the globular isomer and thus hydrogen bonding is likely a strong influence on the 
disulfide preference of globular PnID, with steric hindrance being a lesser factor. Time and 
temperature additionally appear to have a significant effect on PnID, as longer reaction times at a 
decreased temperature appear to result in the favoring of the ribbon connectivity, however only 
when a chaotrope is present. Such a result indicates that the solvent and hydrogen bonding 
interactions that direct the formation of the globular isoform happen at a slower rate and involve 
several complex steps, further providing evidence that hydrogen bond formation is key to 
achieving the globular fold. 
 
 
 
Figure 9: Air oxidations of PnID under various buffering conditions. 
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Figure 10 shows the in vitro oxidative folding of PnID over time in an ammonium 
bicarbonate buffer (pH 8) from a period of 24 to 96 hours. Interestingly the ribbon isomer 
appears to form initially and is slightly favored to that of the globular form during the first 24 
hours. As time progresses, the globular form appears to achieve dominance and at 72-96 hours 
this dominance appears to stabilize. The shift from ribbon to globular is ostensibly either due to 
disulfide bond shuffling which occurs due to the reactivity of the thiols at a basic pH or due to 
aggregation of the ribbon isoform. The case of equilibration being achieved after disulfide 
shuffling at a longer time with the globular form being more highly favored would indicate that 
although the ribbon form appears to be the main peak initially, the globular form is likely the 
thermodynamic isomer and thus natively produced. However a broad peak appeared to form later 
than the ribbon isoform in one of the oxidations and increases in area relative to the loss of the 
ribbon isoform, indicating that the later hypothesis of aggregation is most likely occurring. This 
peak does not occur however in all cases, and may be the result of concentration changes during 
evaporation. 
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Figure 10: Air oxidations of PnID in 0.1M ammonium bicarbonate (pH 8) 
ranging from 24 hours incubation to 96 hours at room temperature. 
 
Glutathione oxidation over a 24-hour period appeared to fully oxidize the peptide and 
produced three isomers (Figure 11). Interestingly the ribbon isomer appeared to be the 
thermodynamic isomer in this case, nearly doubling in size in comparison to the other isomers. 
Strangely however the profile did not match what was observed in the venom duct with the 
earlier eluting peak being larger, indicating that the native form of this peptide may require a 
molecular chaperone when folding.  
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Figure 11: Air oxidation of PnID in 0.1M ammonium bicarbonate (pH 8) in 2:1 
(GSH/GSSG) after 24 hours. 
 
3.2.2 Folding properties of CmrVIA amidated 
 
Previous research has indicated that the ribbon isoform of F-CMrVIA elutes later than the 
globular isoform when subjected to RP-HPLC/UV and is the preferred connectivity of the native 
conotoxin (81). Under all 9 conditions the ribbon isomer of F-CMrVIA appeared to be slightly 
favored (Figure 12). Unlike PnID, the ratio of the globular isomer produced to that of the ribbon 
is approximately 40% and 60% respectively, with the exception of conditions 3, 6, 8, and 9 
where the globular isoform is <40%. In conditions 3 and 6, a third isoform, likely of the beaded 
connectivity, appears to be similar in area to that of the globular form, being approximately 20% 
of the chromatogram. The globular form of F-CMrVIA appears to be greatly reduced by the 
addition of propanol, indicating that organic alcohols have a strong influence on its folding 
pathway. The glutathione oxidation of F-CMrVIA also produced three isomers and favored the 
ribbon isoform over the other two (Figure 13). 
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Figure 12: Air oxidations of F-CMrVIA under various buffering conditions. 
 
 
Figure 13: Air oxidation of F-CMrVIA in 0.1M ammonium bicarbonate (pH 8) in 
2:1 (GSH/GSSG) after 24-hours. 
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3.2.3 Folding properties of MrIA amidated 
 
Unlike PnID and F-CMrVIA, the ribbon conformation of F-MrIA was strongly favored 
under all nine conditions (Figure 14). Since the addition of chaotropes, both strong and weak, did 
not significantly affect the products of F-MrIA, it is unlikely that hydrogen bond formation plays 
a significant factor pre-disulfide bond formation during the folding process. The lack of 
significant variation among the resulting chromatograms despite changes in temperature, time, 
ion pairing, and chaotrope predicates steric hindrance as a significant factor in the in vitro 
oxidative folding pathway of MrIA. Figure 15 shows the glutathione folded F-MrIA that 
displayed little change in comparison to the other folding conditions. 
 
 
  
Figure 14: Air oxidations of MrIA under various buffering conditions. 
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Figure 15: Air oxidation of F-MrIA in 0.1M ammonium bicarbonate (pH 8) in 
2:1 (GSH/GSSG) after 24-hours. 
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3.3 Discussion 
 
The comparative sequences of the F-conotoxins PnID, MrIA, and CmrVIA are shown in 
Table 2 (Chapter 2). Despite all three toxins being highly homologous in their primary 
sequences, and all having the same cysteine framework, their folding properties appear to differ 
dramatically. F-CMrVIA and F-MrIA appear to favor a ribbon disulfide connectivity under all 
conditions, however F-MrIA produces the ribbon form in ~ >80% of its post-folding 
chromatogram despite changes in conditions whereas F-CMrVIA usually produces ~ 60% of its 
chromatogram in the ribbon form. Both of these peptides are in direct contrast to PnID that 
favors the globular form in the absence of chaotropes and organic alcohols and changes in the 
oxidation condition of PnID dramatically influence isomer formation. Initially when comparing 
the sequence of F-MrIA to that of PnID it appears that a small amount of sequence diversity 
(although still largely homologous) plays a distinct role in the preferred disulfide bond 
connectivity of these peptides, as F-MrIA appears to have a highly stabilized and thermodynamic 
ribbon isomer and PnID does not. Surprisingly however when compared to F-CMrVIA, it 
appears that sequence diversity alone is not enough to explain the differences in the oxidative 
folding products. As seen in Table 2 the N-terminus of F-MrIA is extended in comparison to that 
of F-CMrVIA by a Glycine and Asparagine, which accounts for the only differences between the 
two toxins. Therefore this N-terminal truncation appears to be contributing to the loss of 
favorability in the ribbon isoform of F-CMrVIA. This hypothesis is further evidenced in the 
previously published structures of F-MrIA and F-CMrVIA, as well as the structure of F-MrIB, a 
F-conotoxin that is truncated at the first Asparagine residue (Figure 16) (48,67). Therefore it may 
be concluded that the extended N-terminus of F-MrIA helps to shift the folding mechanism of 
these toxins from a mixed-collapse model of oxidative folding to a more framework like model. 
This protection strategy however is directly contrasted by the diversified N-terminal region of 
PnID, which replaces the NGV N-terminal region of F-MrIA with a ST N-terminus and does not 
appear to influence the same stability.  
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Figure 16: Comparison of the lowest 20 solution structures of the sequentially 
truncated F-conotoxins MrIA, MrIB, and CmrVIA. PDB files were obtained from 
wwPDB.org and viewed in YASARA. 
 
The increased preference for the globular disulfide connectivity by PnID is likely due to a 
combination of sequence diversity and post-translational modification. Although PnID contains 
the characteristic cysteine framework of a F-conotoxin, it does not contain a hydroxylated 
Proline in its second intercysteine loop. The addition of an amidated C-terminus is likely causing 
a slight increase in the amount of globular isomer formed in each peptide as was previously 
discovered in F-CmrVIA by Kang et al. (48) however the effect does appear to be slightly more 
significant in the sequence of PnID. The increased preference for the globular isoform could also 
be attributed to the unique N-terminus of PnID or the slight differences in the middle 
intercysteine loop. The center loop of PnID contains key replacements in comparison to other F-
conotoxins such as the change in the stretch GYKL in the traditional F-conotoxins to that of 
GYRM in PnID. This exchange is important because of the possibility of a cation-π interaction 
that may occur during the folding of both toxins, where the traditional F-conotoxins would 
initiate an ε-amino Lysine-π interaction, PnID would initiate a guanidinium Arginine-π 
interaction. This interaction would also be further complicated by the nearby sulfur in the 
Methionine in PnID that has the potential to participate in a favorable Methionine-π interaction, 
increasing the competition of side chain interactions within this region. 
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The combination of the results presented within this chapter and that of the previous chapter 
paints PnID as a unique conotoxin in the appearance of its folding preference and topologies. In 
Chapter 2 it was pointed out that PnID is capable of forming multiple topologies of the globular 
motif through orthogonal synthesis and in this chapter the globular isoform of PnID is further 
evidenced as a significant role carrier in the story of this toxin due to its higher preference in 
comparison to the other F-conotoxins. 
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Chapter 4: Biological activity of PnID and Classification as a  
F-Conotoxin 
 
1.1 Introduction 
 
Conotoxins are currently organized into 12 unique pharmacological families that 
represent the selective molecular targets of these peptides (31,32). The pharmacological families 
of conotoxins at present include the: alpha (nAChR), gamma (Neuronal pacemaker cation 
currents), delta (Voltage-gated Na channels, agonist with delayed inactivation), epsilon 
(Presynaptic Ca channels or G protein-coupled presynaptic receptors), iota (Voltage-gated Na 
channels), kappa (Voltage-gated K channels), mu (Voltage-gated Na channels, blocker), rho 
(Alpha1-adrenoceptors), sigma (Serotonin-gated ion channels), tau (Somatostatin receptor), chi 
(Neuronal noradrenaline transporter), and omega (Voltage-gated Ca channels) families. As 
previously mentioned PnID is very close in homology to the F-conotoxins and is likely a part of 
this pharmacological family. 
In addition to being selective to particular molecular targets, conotoxins often also show 
selectivity to different phyla (26). There are four known types of feeding habits that largely 
correlate with the phyla selectivity of particular venom constituents. These feeding habits 
include: moluscivorous or mollusk eating cone snails, piscivorous or fish eating cone snails, 
vermivorous or worm eating cone snails, and finally cone snails with mixed diets. It has been 
observed frequently that a cone snail of a particular diet will tailor it’s venom peptides to 
specifically attack the receptors of an organism matching its diet. Therefore it is rare to see 
molluscivorous or vermivorous cone snails have venom constituents that are particularly 
effective on mammalian receptors and thus much of the research on the venom from these 
organisms is focused on that which has been derived from piscivorous organisms.  
Despite the major trends in discovery and research, counter examples to the phyla 
selectivity dogma do exist. There have been conotoxins derived from molluscivorous cone snails 
that have displayed activity on mammalian receptors. Of special interest is that of the F-
conotoxins, all of which until recently have been isolated from Conus marmoreous (a 
molluscivore), and have displayed potent activity on the NET (80), which interestingly enough 
has not been characterized in any mollusk species to date, although an alternative transporter, 
likely for octopamine has been identified on the genetic level (83,84). As mentioned previously, 
PnID was isolated from Conus pennaceus, which is also molluscivorous. Due to it’s homology to 
the F-conotoxins it has been assumed to have similar biological activity to the peptides in this 
class. However, since PnID is derived from a mollusk eating cone snail it is also pertinent that 
the peptide be tested not only on this receptor, but for a capacity to be phyla selective.  
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The NET is a type III integral membrane protein consisting of 12 transmembrane 
domains with both termini present on the intracellular side of the membrane. It is located away 
from the synapse and found along the axon, cell body, and dendrites of neurons in the 
parasympathetic nervous system (85,86). It is a high interest target for drug development for 
several major disorders including: severe cancer pain, epilepsy and depression (87). 
As mentioned in the introduction human therapeutics are not the only avenue pursuant of 
these peptides. In consideration of the combined receptor isoform and phyla selectivity of these 
conotoxins, pesticide research and molecular probe design have recently sparked interest.  In 
consideration of these possible developmental routes, the potential biological activity of PnID 
was studied through many different assays to determine phyla selectivity in multiple organisms, 
activity on the NET, and activity on other receptors through extensive screening and whole squid 
axon assays. This work was done collaboratively between the University of Hawaii, Stanford 
University, Vanderbilt University, University of British Colombia, University of the Philippines 
(UP), and the National Institute of Health (NIH). Special thanks go to Dr. Willam Gilly, Dr. 
David Weaver, Dr. Tarah Klassen, Dr. Michael Baumann, Dr. Zenaida Baoanan, and Dispo 
Batinga for their hard work performing assays, writing, and providing insight into the biological 
activity of PnID. 
PnID was tested on many organisms including a fish species Poecillia reticulata, several 
mollusk species including: Achatina fulica, Cypraea caputophidii, Cellana tramoserica, 
Pomacea canaliculata and Jagora asperata; and finally PnID was also tested on a small 
planktonic crustacean known as daphnia, which is known to be extremely sensitive to changes in 
water quality (88). Each of these organisms were chosen to better understand the potential 
biological activity of PnID in different systems.  
The fish species P. reticulata was chosen as a model to study the effects of PnID in 
higher order organisms (i.e. vertebrates). P. reticulata serves as our model vertebrate system due 
to its relative ease of cultivation, the speed at which it reaches maturity, and its ideal size, which 
is appropriate for reaching our target doses. In contrast to the fish assays, the mollusk assays 
provide us with insight into how this peptide may work in nature, whether phyla selectivity 
between fish and mollusks occurs, and whether this peptide may provide insight to the 
development of a future pesticide. 
The mollusk species A. fulica and P. canaliculata were chosen due to their reputations as 
invasive land and marine snails respectively in many tropical regions (89,90), as they are of great 
interest when considering molluscicide development. In contrast J. asperata is a snail native to 
the Philippines and considered economically important and therefore was used to determine the 
potential negative impact PnID may have on the native marine snail population (91). C. 
caputophidii is considered to be the main food source for the Hawaiian native C. pennaceus, the 
closest relative to the Red Sea C. pennaceus, and thus was used to better understand the effects 
of PnID in a native like situation. Finally C. tramoserica was chosen due to the species inability 
to retract into its shell as this action can complicate LD50 and PD50 calculations. 
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1.2 Methods 
 
The assessment of the biological activity of the conopeptide PnID first required a bulk 
production/purification process involving several hundred milligrams of crude material of PnID 
A, PnID B, PnID RevB, mixed and individually isolated isomers from oxidation condition 1 
(Chapter 3), and PnID C (see Chapters 2 and 3) which were all purified to result in 10-20 mg of 
each isomer at >95% purity. Purifications were undertaken as described in chapter 2. Once 
purified, samples were either quantified by weight or through comparative RP-HPLC/UV 
analysis and distributed for use in assays in-house or for use by collaborators. 
 
In-house assays were performed on the fish species Poecillia reticulata and several 
mollusk species including: Achatina fulica, Cypraea caputophidii, and Cellana tramoserica. Fish 
and mollusks were used in an attempt to determine if phyla selectivity plays a role in the toxins 
effect, potency, and/or targeting.  
 
1.2.1 Poecilia reticulata Fish LD50 assay (In-house) 
 
Preparation of peptide solutions 
 
 For the first dose 32 nMoles of each peptide isomer was dissolved in 20 µL of 1x 
phosphate buffered saline (PBS). For the second dose 24 nMoles of each peptide isomer was 
dissolved in 16 µL of 1x phosphate buffered saline and finally for the third dose 16 nMoles of 
each peptide isomer was dissolved in 5 µL of 1x phosphate buffered saline. The calculations 
were as follows: 
 
A= 0.759 µMol/1mL = 0.032 µMole / x mL = 42 µL 
Second dilution (0.024 µMole) = 31.6 µL/2 = 16 µL 
Third dilution (0.016 µMole) = 21 µL/ 4 = 5 µL 
 
B= 0.958 µMol/1mL = 0.032 µMole/ x mL = 33.39 µL 
Second dilution (0.024 µMole) = 25.05 µL /2 = 13 µL 
Third dilution (0.016 µMole) = 16.7 µL /4 = 4 µL 
 
RevB= 0.204 µMol/1mL = 0.032 µMole/ x mL = 156.86 µL 
Second dilution (0.024 µMole) = 117.65 µL /2 = 59 µL 
Third dilution (0.016 µMole) = 78.43 µL/4 = 20 µL 
  
Each isomer was concentrated by speed vacuum and made to 20 µL. 
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Animal preparation and injection procedure 
 
Toxin calculations were completed before preparing animals for this study. A working solution 
of Tricaine (MS-222) used for humane euthanasia was prepared at a concentration of 200 mg/1L. 
A 1X PBS negative control solution was prepared by diluting 10X PBS. 15 Poecilia reticulata 
weighing between 400-600 mg were sacrificed for this study. 9 animals were used for each dose 
(three doses in triplicate), 3 animals were used for the positive control and 3 were used for the 
negative control. Animals were weighed in a beaker containing water from their native 
environment in an effort to minimize stress during the study. Injections were made using a 100 
µL Hamilton syringe and were undertaken by injecting 5 µL of solution at a time. Before each 
injection the syringe was washed three times with bleach, three times with distilled water, and 
three times with 1X PBS. After injection each animal was observed for 24 hours before being 
subjected to euthanasia. Euthanasia was carried out by submersion in Tricaine for 30 minutes 
immediately following rapid freezing in liquid nitrogen. Frozen animals were then autoclaved 
and disposed of through biological waste protocols. LD50 calculations were carried out by the 
method of Meier and Theakston (92). 
 
1.2.2 Mollusk PD50 assays (In-house) 
 
The preparation of peptide solutions was undertaken in the same fashion as mentioned 
above (see Section 4.2.1). PD50 calculations for each organism were carried out using the method 
of Fainzilber and Zlotkin (93). 
1.2.3 Assays performed by the University of the Philippines 
 
Preparation of solutions 
 
Each quantified synthetic peptide isomer was dissolved in 500 µL of normal saline 
solution (NSS) to produce stock solutions of final concentrations (in µM) as listed in Table 4. 
From the stock solutions, 100 µL aliquots of 10 µM concentration were prepared for each 
synthetic peptide isomer. From these aliquots, three test solutions of increasing concentrations: 
1.0, 2.0, and 3.0 µM, named as molluscan biotoxicity assay (MBA) Working solutions, were 
then prepared and used for the bioassay (refer to Table 5).  
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Table 4: Preparation of 10 µM aliquots from Stock solutions. (C= concentration; V= volume). 
Credit to Batinga and Baoanan (UP). 
 
ISOMER C isomer (µM) V isomer (µL) V NSS (µL) C aliquot (µM) V aliquot (µL) 
A 759 1.5 98.5 10 100 
B 338 3.0 97.0 10 100 
C 317 3.5 96.5 10 100 
I 170 6.0 94.0 10 100 
II 712 1.5 98.5 10 100 
III 12 83.5 16.5 10 100 
Mixed 11 91.0 9.0 10 100 
 
 
Table 5: Preparation of MBA Working solutions from 10 µM aliquots. Credit to Batinga and 
Baoanan (UP). 
ISOMER C initial (µM) V initial (µL) V NSS (µL) C final (µM) V final (µL) 
C1 10 10 90 1 100 
C2 10 20 80 2 100 
C3 10 30 70 3 100 
 
Pomacea canaliculata and Jagora asperata immersion assays 
 
Test solutions with volumes of 200 mL were prepared from the MBA Working solutions 
by dilution with deionised water resulting in final concentrations of 0.5, 1.0, and 1.5 nM for each 
of the peptide isomers. Ten snails of P. canaliculata were divided among two glass jars each 
containing 50 mL of a test solution that were sealed with a mesh net to prevent escape of the 
snails. This set-up was followed for all of the twenty-one test solutions that are three different 
concentrations for each of the seven synthetic peptide isomers. The same set-up applied to snails 
of J. asperata. For the negative control, snails were immersed in deionised water and for the 
positive control; snails were immersed in solution that contained Snailkill metaldehyde pellets. 
All the snails were submerged in the glass jars for a total of 72 hours with the temperature 
maintained at 21°C. Snail mortality was then determined at the end of this period by assessment 
of three criteria: retraction reflex of the foot of the snail following tactile stimulation, probing of 
the operculum, and detachment from the vertical surface of the container. The percentage of dead 
snails for each set-up was then recorded. Death of the organism is determined by immobility, 
paleness of color or unresponsiveness to tactile stimulation after the shells were cracked with 
hole on the first body whorl relative to the aperture.  
68 
 
Pomacea canaliculata and Jagora asperata injection assays 
 
For each peptide isomer with three different concentrations as used above, test solution 
was injected intramuscularly into the foot pedal of P. canaliculata and J. asperata with a volume 
of 30 PL with the use of a Hamilton microliter syringe. For the negative control, snails for both 
species were injected with normal saline solution (see Appendix C). Each set-up consisted of 
three snails. Similarly, undiluted test solutions for each peptide isomer with the maximum 
concentrations as listed in Table 4 were also tested with the same procedure. The snails were 
then observed for physical responses within an hour immediately following injection (94). Snail 
mortality was then determined at the end of a 72-hour period by assessment using the criteria 
previously described. The percentage of dead snails for each set-up was also recorded. Death of 
the organism is determined by immobility, paleness of color or unresponsiveness to tactile 
stimulation after the shells were cracked with hole on the body whorl. 
Daphnid Biotoxicity assay  
 
The daphnid biotoxicity assay was done by first filling around 14 mL of natural water 
used for culturing previously tested for physicochemical properties to each of the forty-one test 
tubes. The test tubes were capped with mesh net and sealed with a masking tape and were acid-
washed with 10% v/v HCl and rinsed with dechlorinated water. Thirty-five test tubes were used, 
that is seven isomers with five concentrations per isomer, and filled with the test solutions as 
described previously on Table 5 of the Preparation of Test Solutions for Daphnid Biotoxicity 
Assay. Additional six test tubes were used for positive and negative control triplicates. Each of 
the following solutions, the isomer dilutions and controls, contained ten cultured daphnid 
juveniles 2.0-2.5 mm in length as suggested by Kreutzer and Lampert (95). The negative control 
used the previously tested dechlorinated water while the positive control utilized two dissolved 
SnailKill metaldehyde pellets for each control test tubes. The set-up was maintained with a 
photoperiod of 16:8 hours +/- 1 hour of light and dark cycles for 48 hours.  Results were taken 
into account after the two-day cycle. 
Statistical analysis 
 
All the statistical analyses in this experiment were carried out using IBM SPSS Statistics 
software (Version 20). Statistics at 95% fiducial limits of upper confidence limit and lower 
confidence limit was used. Statistical analyses for mortality of P. canaliculata and J. asperata at 
increasing concentrations of synthetic peptide solution were carried out using Two-way and 
Three-way ANOVA while mortality of D. magna was assessed using the nonparametric 
Independent-Samples Kruskal-Wallis Test.  
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1.2.4 Norepinephrine transporter assay (done in collaboration with the NIH)  
Animal preparation 
 
Male Sprague-Dawley rats (Envigo, Frederick, MD, USA) weighing 250-350 g were 
housed three per cage with free access to food and water and maintained on a 12 hour light/dark 
cycle with lights on from 7:00 a.m. to 7:00 p.m.  Animal facilities were accredited by the 
Association for the Assessment and Accreditation of Laboratory Animal Care, and procedures 
were carried out in accordance with the Institutional Animal Care and Use Committee and the 
National Institutes of Health guidelines on care and use of animal subjects in research. 
Uptake Assays  
 
[3H]Dopamine, [3H]norepinephrine, and [3H]5-HT (specific activity ranging from 30-50 
Ci/mmol) were purchased from Perkin Elmer (Shelton, CT, USA). All other chemicals and 
reagents were acquired from Sigma-Aldrich (St. Louis, MO, USA). Rats were euthanized by 
CO2 narcosis, and brains were processed to yield synaptosomes as previously described 
(Baumann et al, 2013). Rat caudate tissue was used for DAT assays, whereas rat whole brain 
minus caudate and cerebellum was used for NET and SERT assays. Transport activity at DAT, 
NET and SERT was assessed using 5 nM [3H]dopamine, 10 nM [3H]norepinephrine and 5 nM 
[3H]5-HT, respectively. The selectivity of uptake assays was optimized for a single transporter 
by including unlabeled blockers to prevent uptake of [3H]transmitter by competing transporters. 
Uptake inhibition assays were initiated by adding 100 µL of tissue suspension to 900 µL Krebs-
phosphate buffer (126 mM NaCl, 2.4 mM KCl, 0.83 mM CaCl2, 0.8 mM MgCl2, 0.5 mM 
KH2PO4, 0.5 mM Na2SO4, 11.1 mM glucose, 0.05 mM pargyline, 1 mg/mL bovine serum 
albumin, and 1 mg/mL ascorbic acid, pH 7.4) containing test drug and [3H]transmitter. Assays 
were terminated by rapid vacuum filtration through Whatman GF/B filters, and retained 
radioactivity was quantified by liquid scintillation counting. Statistical analyses were carried out 
using GraphPad Prism (v. 6.0; GraphPad Scientific, San Diego, CA, USA). IC50 values for 
uptake inhibition were calculated based on non-linear regression analysis. 
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1.3  Results 
 
1.3.1 P. reticulata Fish LD50 assay (In-house) 
 
Injections at the highest dosage (115 µg/g) demonstrated no lethality in any isomer and 
no significant changes in behavior were observed in comparison to the negative control.  
 
1.3.2 C. tramoserica Mollusk PD50 assay (In-house) 
 
Injections at the highest dosage (115 µg/g) demonstrated no consistent paralysis in any 
isomer and no significant changes in behavior were observed in comparison to the negative 
control.  Despite this some qualitative observations were made about the animals injected. 
 
The animals injected with Isomer A did not appear to elicit too significant of a response 
and the first two displayed a small amount of invagination near the injection site. The third 
organism injected with isomer A would not cling to substrate at all. 
 
The animals injected with Isomer B appeared to display a great amount of invagination of 
the foot nearly exceeding 50% of the foot’s surface. The response was slower when attempting to 
cling to substrate however 2 of the three animals were able to fully cling to the substrate after 10 
minutes. 
 
The animals injected with Isomer RevB also displayed mixed results. For all the animals 
the invagination near the injection site was severe like that of PnID B. The first animal was 
unable to cling to the substrate and was considered paralyzed. The second and third animals were 
able to cling to substrate after 30 minutes but the noticeable effects of invagination also occurred. 
Each organism also demonstrated a loss of water and curling of the foot.  
 
1.3.3 A. fulica Mollusk PD50 assay (In-house) 
 
Injections at the highest dosage (115 µg/g) demonstrated no consistent paralysis in any 
isomer and no significant changes in behavior were observed in comparison to the negative 
control.  Despite this some qualitative observations were made about the animals injected. 
 
 
 
71 
 
1.3.4 C. caputophidii Mollusk PD50 assay (In-house) 
 
Injections at the highest dosage (115 µg/g) demonstrated no consistent paralysis in any 
isomer and no significant changes in behavior were observed in comparison to the negative 
control. 
1.3.5 Pomacea canaliculata immersion assay (done in collaboration with UP)  
 
Figure 17 and Figure 18 illustrate the results obtained for both species from the bioassay 
using the immersion method after a period of 72 hours. For P. canaliculata (Figure 34), results 
indicate that at a concentration of 0.5 nM, only isomers B, C, and M (Mixed) yielded % 
mortalities of 10%, 10%, and 20% respectively. At a concentration of 1.0 nM, % mortalities 
obtained were: isomer A with 20%, isomer B with 10%, isomer I (equivalent to PnID RevB) 
with 20%, isomer II (equivalent to PnID A) with 10%, and isomer III with 20%. At a 
concentration of 1.5 nM, % mortality for isomer A was at 20%, isomer C was at 70%, and 
isomer M was at 10%. For the negative control (deionized water), 10% mortality was obtained; 
for the positive control (metaldehyde), 100% mortality was obtained.  
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Figure 17: Percentage of total mortality of P. canaliculata under three varying 
concentrations for each synthetic PnID isomer tested via immersion method. NC – 
negative control; PC – positive control. Correction of the mortality data from the 
isomers was not performed since the result obtained from the negative control was 
not greater than 10%. Credit to Batinga and Baoanan (UP). 
 
Statistical analysis of the mortality data was performed after percentage values were 
transformed into arcsine values. A two-way ANOVA was used to analyze the mortality of P. 
canaliculata across two independent variables: isomer, and concentration, and the interaction 
between the two. Testing the null hypothesis that states that there is no significant difference in 
the means of mortality among the snails across the type of isomer used, a significance value of 
0.317 was obtained, indicating that the null hypothesis is retained. Similarly, when the null 
hypothesis stating that there is no significant difference in the means of mortality among the 
snails across the concentration used was tested, a significance value of 0.758 was obtained, 
thereby, this null hypothesis is also accepted. However, when the means of mortality of the snails 
were analyzed with regards to the variables of isomer and concentration taken together, a 
significance value of 0.011 was obtained. This indicates that an interaction exists between the 
two variables results and it results in a significant difference in mortality among the snails. These 
are summarized below in Table 6. Among these, isomer C at a concentration of 1.5 nM yielded 
the highest mortality among snails of P. canaliculata. 
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Table 6: Two-way ANOVA test summary for mortality data of P. canaliculata. Credit to 
Batinga and Baoanan (UP). 
 
Source SS df MS F P 
isomer 1655.28 6 275.88 1.26 0.31 
concentration 122.62 2 61.31 0.28 0.75 
isomer * conc. 8160.54 12 680.04 3.10 0.01 
SS = Sum of Squares, df = Degrees of Freedom, MS = Mean Square, F = F statistic, P = P value 
 
1.3.6 Jagora asperata immersion assays (done in collaboration with UP)  
 
Results indicate (Figure 35) that at a concentration of 0.5 nM, only isomers C, II (eq. to 
PnID A), and III each yielded % mortalities of 10%. At a concentration of 1.0 nM, % mortalities 
obtained were: isomer B with 20%, isomer C with 10%, isomer I (eq. to PnID RevB) with 20%, 
isomer II with 10%, isomer III with 20%, and isomer M with 10%. At a concentration of 1.5 nM, 
% mortality for isomer A was at 10%, isomer B was at 20%, isomer C was at 10%, isomer I was 
at 40%, isomer II was at 10%, isomer III was at 30%, and isomer M was at 20%. For the 
negative control (deionized water), zero mortality was obtained; for the positive control 
(metaldehyde), 100% mortality was obtained. 
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Figure 18: Percentage of total mortality of J. asperata under three varying 
concentrations used for each synthetic PnID isomer tested via immersion method. 
NC – negative control; PC – positive control. Credit to Batinga and Baoanan 
(UP). 
 
Statistical analysis of the mortality data was performed after percentage values were 
transformed into arcsine values. A two-way ANOVA was used to analyze the mortality of J. 
asperata across two independent variables: isomer, and concentration, and the interaction 
between the two. Testing the null hypothesis that states that there is no significant difference in 
means of mortality among the snails across the type of isomer used resulted in a significance 
value of 0.289; hence, the null hypothesis is retained. On the other hand, when the null 
hypothesis stating that there is no significant difference in means of mortality among the snails 
across the concentration used was tested, a significance value of 0.013 was obtained, thereby, 
this null hypothesis is rejected. There is a significant difference in means of mortality among the 
snails depending on the concentration by which the isomer was administered. Among the three, 
mortality was highest at 1.5 nM. When the means of mortality of the snails were analyzed with 
regards to the variables of isomer and concentration taken together, a significance value of 0.729 
was obtained. This indicates that there is no interaction between the two variables that can result 
in a significant difference in the means of mortality of the snails. These are summarized below in 
Table 7.  
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Table 7: Two-way ANOVA test summary for mortality data of J. asperata. Credit to Batinga 
and Baoanan (UP). 
 
Source SS df MS F P 
isomer 1525.78 6 254.29 1.32 0.28 
concentration 2080.23 2 1040.11 5.42 0.01 
isomer * conc. 1624.80 12 135.40 0.70 0.72 
SS = Sum of Squares, df = Degrees of Freedom, MS = Mean Square, F = F statistic, P = P value 
 
1.3.7 Comparative statistical analysis of the immersion assays (done in 
collaboration with UP) 
 
A three-way ANOVA was also conducted to assess the mortality of the snails across 
three independent variables, namely isomer, concentration, and species (P. canaliculata or J. 
asperata), and the combinations of interactions among the three. A significance value of 0.635 
suggests that there is no significant difference in the means of mortality in the snails across the 
type of isomer used. Similarly, a significance value of 0.309 suggests that there is no significant 
difference in the means of mortality in the snails of P. canaliculata and J. asperata. In contrast, a 
significance value of 0.030 indicates that there is a significant difference in the means of 
mortality in the snails across the concentration used. Mortality is highest at 1.5 nM. Among 
interactions between variables, a significance value of 0.100, 0.110, and 0.227 suggest that there 
is no interaction between isomer and concentration, between isomer and species, and between 
concentration and species respectively which can result in differences in mortality. However, a 
significance of 0.025 reveals that there is an interaction among the variables of isomer, 
concentration, and species that results in a significant difference in the means of mortality in the 
snails. These are summarized below in Table 8. The highest mortality was observed among P. 
canaliculata at a concentration of 1.5 nM for Isomer C. 
  
76 
 
Table 8: Three-way ANOVA test summary for mortality data of the snails. Credit to Batinga and 
Baoanan (UP). 
 
Source SS df MS F P 
isomer 887.52 6 147.92 0.72 0.63 
concentration 1573.03 2 786.51 3.83 0.03 
species 217.67 1 217.67 1.06 0.30 
isomer*conc. 4204.99 12 350.41 1.70 0.10 
isomer*species 2293.55 6 382.25 1.86 0.11 
conc.*species 629.83 2 314.91 1.53 0.22 
isomer*conc.*species 5580.35 12 465.02 2.26 0.02 
SS = Sum of Squares, df = Degrees of Freedom, MS = Mean Square, F = F statistic, P = P value 
 
1.3.8 Pomacea canaliculata injection assay (done in collaboration with UP) 
 
Table 9 summarizes the qualitative data collected from the bioassay performed on P. 
canaliculata using the injection method. Observations were made and recorded at the following 
periods: immediately after injection, after 30 min, after 1 hour and the next hour that followed, 
and finally, after 24 hours. 
 
Table 9 shows that a general reaction to injection was the contraction of the foot pedal 
and closing of the opercula, however, the speed of which slightly varied among the snails. After 
half an hour, the opercula appeared to be tightly shut in all the test organisms with some 
noticeably secreting copious amounts of mucous. After an hour, the opercula have already 
opened but in varying degrees: some only slightly, others partially, and some completely opened 
with the foot pedal once again exposed. For good measure, observations were also noted after 2 
hours with some snails beginning to exhibit active movement. After the cut-off of observation at 
24 hours, mortality was tested; however, all snails were still alive with only a few still dormant. 
Lethality of the isomers was not established based on the results, given the observation period set 
for this bioassay.  
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Table 9: General observations on the behavioral response of P. canaliculata to test solutions 
administered via injection at various times of observation. Credit to Batinga and Baoanan (UP). 
 
Isomer 
Qualitative Response/ Behavior in P. canaliculata 
Upon Injection At 30 mins. At 1 hr. At 2 hrs. At 24 hrs. 
A 
Contraction of foot pedal; 
Delayed retraction and 
closing of operculum 
Operculum completely closed 
and receded into shell 
Slightly opened 
operculum 
Slightly opened 
operculum 
Dormant 
B 
Contraction of foot pedal; 
Delayed retraction and 
closing of operculum 
Operculum completely closed 
and receded into shell; 
mucous secretion 
Slightly opened 
operculum 
Slightly opened 
operculum 
Dormant 
C 
Contraction of foot pedal; 
Average retraction and 
closing of operculum 
Operculum completely closed 
and receded into shell; 
mucous secretion 
Completely 
p ned 
operculum; 
exposed foot 
pedal 
Active movement Alive 
I 
Contraction of foot pedal; 
Abrupt retraction and 
closing of operculum 
Operculum completely closed 
and receded into shell 
Slightly opened 
operculum 
Completely opened 
operculum; exposed 
foot pedal 
Alive 
II 
Contraction of foot pedal; 
Average retraction and 
closing of operculum 
Operculum completely closed 
and receded into shell; 
mucous secretion 
Slightly opened 
operculum 
Active movement Alive 
III 
Contraction of foot pedal; 
Delayed retraction and 
closing of operculum 
Operculum completely closed 
and receded into shell; 
mucous secretion 
Partially opened 
operculum 
Active movement Alive 
M 
Contraction of foot pedal; 
Average retraction and 
closing of operculum 
Operculum completely closed 
and receded into shell 
Partially opened 
operculum 
Active movement Alive 
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1.3.9 Jagora asperata injection assay (done in collaboration with UP) 
 
Table 10 shows that a general reaction to injection was the contraction of the foot pedal 
and abrupt retraction and closing of the opercula. After half an hour, some of the opercula were 
slightly and partially opened while some remain shut. After an hour, most snails began actively 
moving while a few were dormant still. At the second hour, all snails have demonstrated active 
movement. After the cut-off of observation at 24 hours, mortality was also tested; however, all 
snails were still alive. Similar to P. canaliculata, lethality of the isomers was not established 
based on the results within the 24-hour observation period.  
 
Table 10: General observations on the behavioral response of J. asperata to test solutions 
administered via injection at various times of observation. Credit to Batinga and Baoanan (UP). 
 
Isomer 
Qualitative Response/ Behavior in J. asperata 
Upon Injection At 30 mins. At 1 hr At 2 hrs At 24 hrs 
A 
Contraction of foot pedal; 
Abrupt retraction and 
closing of operculum 
Closed operculum Dormant Active movement Alive 
B 
Contraction of foot pedal; 
Abrupt retraction and 
closing of operculum 
Partially opened  
operculum 
Active movement Active movement Alive 
C 
Contraction of foot pedal; 
Abrupt retraction and 
closing of operculum 
Slightly opened  
operculum 
Active movement Active movement Alive 
I 
Contraction of foot pedal; 
Abrupt retraction and 
closing of operculum 
Closed operculum Dormant Active movement Alive 
II 
Contraction of foot pedal; 
Abrupt retraction and 
closing of operculum 
Partially opened  
operculum 
Active movement Active movement Alive 
III 
Contraction of foot pedal; 
Abrupt retraction and 
closing of operculum 
Closed operculum Dormant Active movement Alive 
M 
Contraction of foot pedal; 
Abrupt retraction and 
closing of operculum 
Completely opened 
operculum  
Active movement Active movement Alive 
 
1.3.10 Daphnid Biotoxicity assay (done in collaboration with UP) 
 
A biotoxicity assay using the seven peptide isomers was also performed on another test 
organism Daphnia magna. A different experimental design was used for the assay wherein five 
different concentrations (increasing geometrically) were tested for each isomer instead. Figure 19 
illustrates the results obtained after 48 hours of immersion. At a concentration of 3.1 nM, only 
isomer III yielded a result, which is 10% mortality. At 6.25 nM, only isomer A yielded a result: 
20% mortality. At 12.5 nM, only isomer A too yielded a result but at 10% mortality. At 25.0 nM, 
isomers C, I, and III each yielded 10% mortalities. At 50.0 nM, isomers II, III, and M each 
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yielded 10% mortalities as well. For the negative control (tap water), zero mortality was 
obtained; for the positive control (metaldehyde), 53% mortality was obtained. 
 
 
 
Figure 19: Percentage mortality of D. magna under five varying concentrations 
used for each synthetic PnID isomer tested in the biotoxicity assay: NC – negative 
control; PC – positive control.  
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Statistical analysis of the mortality data was performed after percentage values were 
transformed into arcsine values. Preliminary statistical tests for assumptions of normality and 
homoscedasticity show that the data do not satisfy these assumptions, hence, a nonparametric 
test, Independent-Samples Kruskal-Wallis Test was performed. Testing the null hypothesis that 
states that the distribution of mortality is the same across categories of isomer used, a 
significance value of 0.472 was obtained, indicating that the null hypothesis is retained. 
Similarly, when the null hypothesis stating that the distribution of mortality is the same across 
categories of concentration used was tested, a significance value of 0.556 was obtained, thereby, 
this null hypothesis is also accepted.  
 
1.3.11 Norepinephrine transporter assay (done in collaboration with the NIH) 
 
Inhibition of the monoamine transporters by the A and B (as well as reverse) isomers of 
PnID in comparison to that of cocaine indicated that the most potent and selective isomer of 
PnID is that of the A (ribbon) isoform (Figure 20). This is unsurprising as it was mentioned 
earlier in this chapter and in previous chapters that the F-conotoxins are known for their ribbon 
fold and selectivity for the NET. Surprisingly the potentcy of PnID A appears to be nearly 20 
fold weaker than MrIA as its IC50 was calculated to be 10 +/- 1.75 μM. Another surprising 
discovery was that the PnID B isoform was able to inhibit each monoamine transporter non-
selectively with a smilar potency at low doses whereas PnID RevB appeared to lose activity 
altogether.   
 
Follow up assays (Figure 21) indicated that the potency for PnID B is significantly less 
than that of the known F-conotoxins as the estimated IC50 of it is >100 μM at the NET and even 
higher for that of the other monoamine transporters. Thus it appears that at the monoamine 
transporters the most relevant peptide of consideration is the A isoform. 
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Figure 20: Uptake plots showing the comparative dose-response inhibition of the 
monoamine transporters by PnID A, PnID B, PnID RevB, and cocaine at 
concentrations up to 10 μM. 
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Figure 21: Uptake plots showing the comparative dose-response inhibition of the 
monoamine transporters by PnID A, PnID B, PnID C and cocaine at 
concentrations up to 100 μM. 
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1.4  Discussion 
 
As previously mentioned, F-conotoxins are of interest because of their high selectivity for 
the NET. The NET is just one of several human monoamine transporters which has been 
implicated in the pain transduction pathway, as a key regulator of orthostatic intolerance and 
seizures, as well as having a significant role in depression and addiction (87). Since the NET has 
so many roles in the human parasympathetic nervous system it is crucial not only to study the ion 
channel and its related physiology but environmental regulators which can significantly affect its 
function and thus human disease and behavior. Therefore PnID, a conopeptide which not only 
contains a significant amount of homology to the known F-conotoxins but also demonstrates 
unique folding behavior could be considered low-hanging fruit when considering the depth of 
information obtainable from its study.  
In an attempt to assess the potential of PnID as a human therapeutic or environmental 
pesticide it was tested on several economically important and invasive snail species, Daphnia 
magna, as well as fish and the monoamine transporters. The LD50 and PD50 snail assays 
undertaken by injection yielded very inconsistent results qualitatively and provided no real 
quantitative data, especially in the case of the organisms capable of shell retraction. The two 
main issues encountered in this assay were the inconsistency of the organism’s response to 
injection and the erratic times at which the snails would extend out of their shells. Since the 
assays relied on the snails’ ability to cling to substrate, full or partial retraction created 
significant difficulty when measuring paralysis. Another significant hurdle encountered during 
the injection assays was confirming penetration of the needle when performing the injections. In 
contrast to fish, it is difficult to tell when the needle penetrates the snail membrane because of its 
lack of cartilage or skeletal structure that allows it to flex readily with the pressure of the needle. 
Lastly the mucus produced by the snails may aid in reducing the potency of the peptides by 
absorption into its glycoprotein network or through the introduction of humoral immune 
responses (96).   
The fish injection assay also yielded minimal results when injected with relatively high 
doses of peptide. This result may be explained by two potential reasons. First Poecilia reticulata 
may not be affected by PnID in particular due to a lack of homology in their corresponding 
monoamine transporters to that of the human or snail counterparts. Secondly, the results of the 
IC50 determination of PnID on the monoamine transporters display a micromolar potency for 
even the most active isomer, indicating that standard concentrations may not be able to induce 
lethality or even measurable paralysis.  
Interestingly the immersion assays were much more successful in yielding quantitative 
data on the activity of the PnID isomers. Isomer C appeared to significantly increase mortality of 
the invasive sea snail P. canaliculata in a dose-response manner. This result is significant 
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because it is the first reported instance of biological activity in a peptide toxin restrained by 
vicinal disulfide bonds.  
The activity of the isomers of PnID on the monoamine transporters yielded fairly 
expected results. Out of all the isomers PnID A appeared to be the most selective for the NET 
with an IC50 of 10.33 (+/- 1.75) µM in comparison to the DAT and SERT to which it was 
inactive up to concentrations of 100 μM. Since PnID A is the ribbon isomer and all known F-
conotoxins exist in such a form, this result was not surprising. PnID RevB and PnID C displayed 
almost no inhibition of any of the monoamine transporters while PnID B appeared to yield a 
small amount of inhibition on the NET and no activity on any other transporter at higher doses. 
Study of the ribbon conformation of MrIA has yielded pertinent information in the past 
about structural requirements for the maintenance of activity on the NET, Particularly the 
conservation of an inverse J turn between the residues Gly 6 – Lys 8 (4). Since these residues are 
homologous in the sequence of PnID, (Gly 5 – Arg 7) it is likely that the ribbon conformation of 
PnID yields a similar J turn. Interestingly a small amount of inhibition of the NET also occurred 
with the globular topology PnID B but not in PnID RevB, which may be indicative of a similar 
turn forming in only the PnID B topology.  
Past study of MrIA by alanine scan has also shown that replacement of the Lys 8 residue 
with an arginine resulted in less binding capacity to the NET. This finding could explain the 
lower activity of PnID A as this replacement occurs in it’s native sequence. This replacement is 
interesting however as Conus pennaceus is a molluscivore and as stated in the beginning of the 
chapter, monoamine like receptors have yet to be fully determined in mollusks. Therefore a 
residue replacement in this position could produce a more favorable binding to particular 
mollusk receptors that have not yet been fully elucidated.  
The slight activity on the NET by PnID B and lack of activity of PnID RevB presents an 
interesting case that topological isomerization can produce differential biological activities and 
thus likely different overall structures. To the best of our knowledge, globular topological 
isomerization of small peptides containing two disulfides is a property that has not yet been 
reported in literature. Although disulfide bond connectivity is often reported in many articles, the 
order of disulfide bond formation by two step synthesis is not. The results demonstrated in this 
section show that disulfide bond topology which can be manipulated by the order of bond 
formation may result in weaker or less selective biological activity of a peptide. Therefore 
structure determination of disulfide oxidized peptides presents a key factor in confirming the 
appropriate conformation of these peptides. 
Clear and seemingly contradictory differences arose between the results yielded from the 
mollusk based assays and that of the receptor based assays. PnID C appeared to have a 
significant effect on the mortality of the invasive snail P. canaliculata but did not appear to 
affect any of the monoamine transporters. These results, although seemingly contradictory at first 
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glance make sense when considering the molecular physiology of mollusks. As previously 
mentioned, mollusks do not contain traditional monoamines such as dopamine or norepinephrine 
but instead utilize the catecholamines tyramine and octopamine for their neuronal signal 
transduction processes (83,84).  Additionally gene sequences which share homology to 
transporters for catecholamines have been partially identified for some mollusks, which may 
suggest that PnID C could be an inhibitor of such a transporter.  
Although it is not as pharmacologically potent as its F-conotoxin cousins, PnID contains 
many interesting facets within its’ variable structure and shares a similar IC50 to that of some 
currently approved FDA drugs such as modafinil, a treatment for narcolepsy (97). Thus further 
research and development of PnID may be beneficial when considering the development of 
similar drugs. 
  The results from this chapter show for the first time that the alternative disulfide bonding 
strategies of a F-conotoxin not only adapt to structural topologies previously unconsidered by 
peptide folding theory, but that these topologies have differences in potency and selectivity. 
Furthermore PnID has shown to produce the first biologically active peptide toxin containing 
vicinal disulfides and this activity was demonstrated in an invasive snail species. Thus the 
information presented within this chapter could have significant implications for not only the 
pharmaceutical industry but also in pesticide development.  
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Chapter 5: Solution Structure of the Topological Isomers of PnID 
1.5  Introduction 
 
In biochemistry structure and function are considered to be intimately related. When the 
structure of a biological molecule is perturbed even slightly, there are often significant 
consequences for the activity of that molecule (98).  This theme can be observed across many 
different biological molecules including proteins, peptides, DNA and RNA. Due to the 
ubiquitous nature of the structure-activity relationship, the structures of many biological 
molecules have been vigorously studied over the last century in order to glean further 
information about the properties of these molecules and their associated motifs.  Two methods of 
structure characterization of biological molecules have taken precedence in the field of structural 
biology which include: X-ray crystallography and nuclear magnetic resonance spectroscopy (5).  
 
X-ray crystallography is a technique which exploits the relationship between the 
scattering angles of X-rays and the size of a unit cell in a crystal to determine spatial 
relationships of crystallized molecules (99). This method of structure determination has resulted 
in the elucidation of countless protein structures over the last century including the famous DNA 
double helix (100). Although this method has provided a vast amount of knowledge on 
biomolecular structure over the years it is not without its limitations. Since the principle of X-ray 
crystallography relies on determining the size of a unit cell in a crystal by scattering, the 
molecule of interest must first be successfully crystallized in order to achieve sufficient 
information for structure determination. Crystallization can be a complex process, as the route to 
crystallization is often largely different among proteins and peptides (5). Thus it is not unheard 
of to have hundreds of trials of attempted crystallization before achieving results suitable for 
structure determination. It could also be considered disadvantageous that crystallography relies 
on the material of interest to be held in a solid state. Often crystallization, although yielding an 
accurate structure in the crystalline state, will not provide information on how the molecule 
would behave in solution, which could be of considerable disadvantage if that molecule contains 
multiple conformations in solution, or if effects on solvation wish to be studied. 
 
In contrast NMR spectroscopy provides an avenue to study the solution states of 
biological molecules. Using NMR to study bio-molecular structure is a relatively new practice in 
comparison to crystallography as the advent of the techniques necessary for full structure 
elucidation began in the year 1977 (5). One of the most significant techniques to be developed 
around this time and often considered to be the most crucial is the use of the Nuclear Overhauser 
Effect (NOE) to study interatomic differences in a molecule. Although the NOE was an observed 
phenomenon in 1962 (101), it was not used to efficiently study biomolecule structure until Kurt 
Wüthrich began his work in the late 1970s. Dr. Wüthrich went on to win a Nobel prize in 
chemistry in 2002 for the development of his techniques. 
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Unlike X-ray crystallography NMR spectroscopy is non-destructive and does not irreversibly 
alter a sample, thus making it an efficient technique which can be repeated without sample 
replacement (5). In addition higher field strength instruments combined with sensitive 
cryoprobes may be used to study the structure of molecules in concentrations on the high 
micromolar scale. Also unlike crystallography NMR allows for the study of dynamic processes 
of molecules in solution such as conformational changes, proton exchange, and even binding. A 
fallback of NMR however is the inability to view cofactors with inappropriate spin, such as 
calcium molecules which may be critical to structure formation (5). 
 
1.5.1  Introduction to the Basics of NMR Spectroscopy 
 
An NMR spectrometer (Figure 22) is a machine that generates an electromagnetic field, is 
capable of producing radiofrequency pulses, measuring changes in the magnetic environment, 
and is capable of outputting data based on these changes. NMR spectroscopy is a technique that 
utilizes information obtained by altering the magnetic field of particles that contain particular ½ 
spin states. A particle such as a proton contains a particular spin which when subjected to a 
magnetic field will statistically align with the direction of that magnetic field so that it remains in 
a state of low energy. At this point a radiofrequency (rf) pulse may be applied to the proton at its 
Larmor frequency, such that the energy is absorbed by the proton and that proton then climbs in 
energy state, thus misaligning with the magnetic field produced by the spectrometer. After 
absorbing the energy from the rf pulse and opposing the magnetic field the proton will then fall 
back into it’s lower energy state thus producing a decay signal which may then be interpreted by 
the spectrometer as a particular change in current (5). This resultant information is 
mathematically transformed by a computer and describes things such as how many protons occur 
on a molecule, how electronegative each environment is, and how many other protons neighbor 
the one of interest (Figure 23). This information often combined with supplemental information 
from mass spectrometry provides for the determination of structure of small molecules, and 
provides information on spin systems in larger biological molecules. A spin system is a group of 
spins that are connected by scalar or through bond j-coupling.   
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Figure 22: A 500 MHz NMR spectrometer used at the University of Hawaii at 
Manoa. Photo courtesy of the UH Manoa Chemistry website. 
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Figure 23: One-dimensional NMR spectrum of bromoethane. The three protons 
on carbon 2 are represented as the more upfield peak (closer to 1 ppm) whereas 
the protons on carbon 1 are more downfield, due to the shielding effects of 
bromine. The splitting pattern reveals how many neighbors are present by the n+1 
rule with the protons on carbon one having a splitting pattern of 3+1 making a 
quartet, while the protons on carbon 2 have a splitting pattern of 2+1 resulting in a 
triplet. The amount of protons on each carbon is determined by the relative area 
integration of each peak. 
Two-dimensional NMR spectroscopy furthers the information obtainable by single 
dimensional NMR spectroscopy by providing further elucidation of particular spin systems 
through scalar or j-coupling, as well as interatomic distance information through dipolar 
coupling. This information is achieved by following a scheme of preparation, evolution, mixing, 
and detection, where different experiments are achieved by altering the evolution and mixing 
periods (5). 
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1.5.2 Modern Techniques in Solution Structure Determination of Peptides 
 
The elucidation of the solution structures of biological molecules by NMR is often 
undertaken as an iterative, step-wise process and is an ever-expanding discipline. The following 
section will provide the reader with a basic understanding of this process but is in no way an 
exhaustive guide to all avenues of solution structure determination, nor should it serve as a 
complete introduction to the topic. Textbooks such as “NMR of Proteins and Nucleic Acids” by 
Kurt Wüthrich and “Molecular Modeling Principles and Applications” by Andrew R. Leach are 
recommended starting points to anyone interested in this field. 
 
Dissimilar to crystallography, information obtained by NMR alone is not sufficient to 
determine the structure of a molecule. Instead NMR solution structure relies on a priori 
information that can be narrowed down using a combination of known laws and measured 
energies for the conformations of various biological molecules and the use of efficient problem 
solving algorithms. The modern techniques for the tertiary solution structure determination of 
peptides in particular may be undertaken using either proton or hetero-nuclear NMR 
experiments. Important experiments include single dimensional NMR and a series of two-
dimensional experiments including correlation spectroscopy (COSY), total correlation 
spectroscopy (TOCSY), and NOE or Rotational Overhauser (ROE) spectroscopy (all of which 
will be further discussed later). In addition another helpful experiment is exclusive correlation 
spectroscopy (ECOSY). The data obtained from each of these experiments is reliant on each 
other and requires careful interpretation as many pitfalls (which will be discussed later) may 
arise from erroneous interpretation. Once properly interpreted, the information obtained is 
converted into restraints used by a computer program which applies an algorithm to solve for 
low energy structures and converges on a set of structures representative of the molecules lowest 
thermodynamic energy state in solution. 
 
COSY and TOCSY experiments result in information on the scalar (through bond) coupling 
of ½ spin atoms in a molecule. In proton NMR, COSY is absent of mixing and provides 
information on which protons are scalar coupled to just three bonds away, providing an avenue 
of plotting where protons are in a particular spin system. If the information is complete, COSY 
can allow for the total elucidation of a particular spin system, often times however this is not the 
case. An alternative and often supplemental experiment is TOCSY, which at appropriate mixing 
times can provide information on the scalar coupling of an entire spin system.  
 
In contrast NOESY and ROESY are experiments that result in information on dipolar 
(through space) coupling. This technique will provide information on distances between ½ spin 
atoms in relation to each other in space. Determining whether ROESY or NOESY should be 
used is decided by how fast the molecule tumbles in solution, a property related to molecular 
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weight. If a molecule is generally larger than 1100 Da. NOESY often yields better data whereas 
if a molecule is smaller, ROESY appears to be more effective.  
 
Solution structure determination by NMR requires a combination of these techniques. At 
minimum a single dimensional NMR spectrum to determine splitting, number of protons, and in 
the case of peptides and proteins to assess folding and proton exchange. Then either a COSY or 
TOCSY (usually both) is needed to determine which spin system and consequently which amino 
acid each proton belongs to. Finally a dipolar coupling experiment is required such as NOESY or 
ROESY to build restraint lists for use in a restrained MD program. 
 
1.5.3 Sequence determination and peak assignment 
 
Correctly assigning peaks in an NMR spectrum is essential to beginning the structure 
determination process. In order to start the assignment operation a processed one-dimensional 
spectrum must be assessed to determine if a peptide or protein adopts a stable conformation in 
solution and if impurities are present within the sample. The corresponding protons should match 
the protons in the peptide of interest. Fewer protons than expected may be observed due to the 
exchange of amide protons with deuterium in the solution, or due to overlap with the water 
signal. Such issues may be corrected by changing parameters such as temperature and pH. A 
fully folded peptide will produce amide peaks (in the downfield region) that are well dispersed, 
meaning that they occupy different electromagnetic environments due to intramolecular 
hydrogen bonding or specific positioning as a result of the folding process. A folded peptide 
spectrum in proton NMR should consist of a downfield amide region between 10-7 ppm, an 
aromatic region between 7-6 ppm, an aliphatic region between 6-4 ppm, and a methyl region 
between 3-0 ppm (Figure 24).  
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Figure 24: Regions of a proton spectrum in a general folded peptide. This figure 
was adapted from Kurt Wüthrich 1986 (5). 
Once each peak type has been correctly identified, two-dimensional scalar coupling data 
given by COSY or TOCSY experiments may be used to determine which spin system (and thus 
corresponding amino acid) each peak belongs to. A two-dimensional spectrum consists of a one-
dimensional spectrum oriented topographically and horizontally, where cross peaks between two 
peaks in the diagonal section provide information on the coupling of those protons (Figure 25). 
In COSY this would represent scalar coupling, whereas in NOESY this would represent dipolar 
coupling. Once each spin system has been determined by COSY or TOCSY, the connections of 
those spin systems in space may be determined by dipolar experiments. In order to determine the 
sequence of a particular peptide and thus begin assigning protons based on position within the 
peptide, the fingerprint region of the dipolar spectrum would need to be ascertained. The 
fingerprint region consists of α proton and amide proton couplings. Finding a known position in 
a peptide, and then tracing couplings from that amino acids alpha proton to the adjacent amide 
protons allows for the determination of the peptide’s sequence in a fashion known as a sequence 
walk (5). Once the sequence has been determined and each amino acid has been assigned, 
restraints may be calculated from the intensities of the observed dipolar coupled crosspeaks. 
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Figure 25: A generalized example of a two-dimensional spectrum of a peptide. 
Region g represents the fingerprint region. This figure was adapted from Kurt 
Wüthrich 1986 (5). 
 
1.5.4  Calculating Distance Restraints  
 
As previously mentioned, data from NMR spectroscopy alone is insufficient to fully 
determine the solution structure of a bio-molecule. In order to determine the complete structure 
of a biological molecule NMR data must be used in tandem with MD or distance geometry. In 
peptides, once each amino acid’s spin system has been fully described by the COSY or TOCSY 
data, dipolar couplings must be measured with NOESY or ROESY data. The intensity of these 
peaks will then be used to create what are known as restraints, which will be used by a MD 
package to determine structure.  
 
The relationship between distances of protons and NOE intensity may be described as 
ଵ
௥షల ≅ 𝑁𝑂𝐸 𝑖𝑛𝑡𝑒𝑛𝑠𝑖𝑡𝑦 where r is the distance of the protons involved in the dipolar coupling. 
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Therefore if known distances occur within a molecule such as vicinal protons in an aromatic ring 
(Figure 41), restraints may be calculated based on this relationship and the relative volumes of 
other peaks within the spectrum. An example of this would be if the previously described protons 
occurred at a known distance of 2.5 Å (Figure 26) and had a peak volume of 1.5 × 10଻, a 
distance of 3.5 Å could be calculated using the corresponding formula ௏ಲಳ(௥ಲಳ)షల =
௏ಳ಴
(௥ಳ಴)షల
 where 
VAB is the volume of the peak corresponding to protons A and B (in our case the two vicinal 
protons on our aromatic ring) and rAB is the distance between those protons . BC would then be 
other protons in the spectra corresponding to a different distance, in our case we may choose 
another distance such as 3.5 Å. Substitution of these values with our example equation would 
produce: ଵ.ହ×ଵ଴
ళ
(ଶ.ହ Å)షల =
௏ಳ಴
(ଷ.ହ Å)షల and thus 𝑉஻஼ = 1.5 × 10
଻((ଷ.ହ Å)
షల
(ଶ.ହ Å)షల) Or 2.0 × 10
଺. Such a 
relationship provides for the establishment of what are known as restraints, or regions of peak 
volumes that correspond to a particular distance. In the previously worked example the restraint 
established would be that between peak volumes 1.5 × 10଻ and 2.0 × 10଺ a proton would likely 
be between 2.5 and 3.5 angstroms. 
 
Figure 26: Vicinal protons of an aromatic ring (benzene), showing the known 
distance of 2.5 Å. 
The restraints determined by this method may be binned into different categories of peaks, often 
coined strong (0 - 2.5 Å), medium (0 - 3.5 Å), weak (0 - 4.5 Å), and very weak (0 - 5.5 Å) peaks. 
Once appropriately calculated, specialized assignment software may be used to measure the 
volumes of each peak within a dipolar spectrum, allowing for automated output of restraints into 
intended bins that are then compiled into a restraint list. An example of a restraint list for use by 
a MD package using the XPLOR format can be seen in Figure 27. 
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Figure 27: An example of binned restraint lines of code in the XPLOR format created by 
the assignment software SPARKY. Assign acts as an operator which tells the MD 
program to take the proceeding two specific atom positions and restrain them between a 
lower bound distance, an upper bound distance, and allow for a particular error (the third 
column of numbers, left to right respectively). 
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1.5.5  “Restrained” Molecular Dynamics (MD) 
 
Once a restraint list has been made it may then be of use in an MD package. MD is an in-
silico technique for studying the behavior and movement of molecular models (102). In the 
process of determining the NMR solution structures of molecules, MD simulations are 
considered critical as the information generated from various NMR spectroscopy experiments 
only provides information on possible distances between atoms and allows for the exclusion of 
unlikely or impossible solutions. The combination of restrained MD simulations and data from 
NMR spectroscopy results in a semi empirical solution which takes into account three important 
factors including: restraints generated from NMR spectroscopy, a molecular force field, and a 
problem solving algorithm.  
A force field is complex descriptor of molecules that allows them to be modeled as 
realistically as possible while maintaining efficiency within a program. Current force fields for 
use in MD packages output basic information such as energy changes related to deviations in 
position from a molecules thermodynamic equilibrium. In a basic force field these changes often 
include bond length, angle, torsional angle, electrostatic interactions, van der Waals interactions, 
and solvent interactions (102). Interestingly, for the sake of efficiency Newtonian physics often 
suffices as a replacement for quantum mechanics when considering the calculation of energies 
derived from these properties. The Borne-Oppenheimer approximation allows for the 
consideration of atoms as large Newtonian objects in comparison to their electron counterparts, 
as protons in contrast are very much larger and are considered to be localized, whereas electrons 
are not. Since only atom positions are of interest in NMR solution structure determination, 
electrons may be removed from the calculations. This approximation allows for the properties of 
atoms such as bond length and angle changes to be modeled with simple harmonic equations, 
allowing for a more rapid calculation of atom position, movement from thermal equilibrium, and 
thus calculation of approximate free energy (102). 
A molecular force field is an essential tool for energy calculation however it is only just 
that, an algorithm is required to take the information outputted by the force field to be used to 
solve the conformational problem. A popular problem solving algorithm used in many MD 
packages is known as simulated annealing. Annealing is a term stemming from metallurgy and is 
used to characterize the process of heating and cooling metal in order to arrange the atoms in the 
metal from a disordered state to that of a crystalline one. This process parallels as a near perfect 
analogy to solution structure determination as it often begins with a disordered molecule and 
ends in a low energy, ordered state.  
Simulated annealing, much like the annealing process fulfills the requirements of taking a 
problem such as a disordered molecule and results in the output of a more ordered one, except 
that it is done in-silico and fed information to restrain particular parameters. The simulated 
annealing algorithm consists of several important key factors including: a random global search 
function, a local minima search function, a greed function, and a cost function. The simulated 
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annealing process uses each of these functions to converge on a particular lowest energy “cost” 
which corresponds to particular atom positions when considering the output from the force field. 
Thus whatever particular positions the atoms are in when the force field has output the lowest 
energy is accepted as the lowest energy conformation of the molecule and thus what would be 
observed by nature. If convergence of output is achieved, the resulting atom positions may be 
considered real. 
Although the process of problem solving using MD simulations through the route of 
simulated annealing with an advanced force field could be considered highly more efficient than 
brute force problem solving, for many molecules it would take a near millennia to solve a 
solution structure without any form of initial empirical input. Thus restrained MD simulations 
allow for the input of empirical information such as distance restraints derived from NMR 
spectroscopy experiments that shrink the searchable energy plane for the algorithm’s output. 
This in turn allows the process to speed up dramatically and for solutions to be found within a 
matter of hours.  
Finally once convergence of data from multiple outputs has been achieved, that molecule 
must be examined for possible flaws. It is often encountered that the first output of a set of 
solution structures from an MD package is incorrect or contains minor or major inaccuracies. 
These problems can arise from situations that include inaccurate assignment of peaks, 
contamination, multiple solution structures, ambiguous data, errors in calculation of peak 
volume, or insufficient data.  In order to determine if the outputted model is representative of the 
true solution structure, assessment must be undertaken. 
Peptide structures may be assessed in multiple ways including comparison of RMSD of 
all outputted structures, Ramachandran plotting and analysis, measurement of positions in 
comparison to homologous solved structures, planarity of bonds, collisions of atoms, and much 
more. A popular program for the assessment of structures is known as PROCHECK and 
examines much of what has been previously discussed. 
 
1.5.6  Additional information obtained from NMR spectroscopy 
 
NMR spectroscopy is highly versatile tool when considering the amount of information 
that can be probed in a biological molecule. Solution structure determination may be 
complemented by particular instances of data that may be retrieved from information output by 
the NMR instrument. Some of the most pertinent pieces of information include particular 
couplings which might provide evidence for disulfide bond connectivity, isomerization of 
Proline, formation of secondary structure, torsional angle determination, and hydrogen bond 
formation (5). 
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As previously mentioned disulfide bonds may be considered one of the most important 
post-translational modifications of peptide toxins, especially conotoxins as their structures are 
often highly dependent on appropriate disulfide bond formation. Using a combination of the 
previously discussed NMR techniques it is therefore possible to assign particular cysteines 
within a sequence and calculate distances between heavy atoms or protons between particular 
cysteines. Thus if the beta protons of two cysteines are in the proximity expected of a disulfide 
bond, it is possible to observe these as medium or weak crosspeaks. Despite providing a small 
amount of evidence for the occurrence of disulfide bonds between two particular cysteines these 
crosspeaks can be misleading, as cysteines may be in close proximity due to the fold of the 
peptide backbone, and may not necessarily be in a disulfide bond with each other.  
In addition to individual crosspeaks providing information about elements of the 
peptide’s conformation and secondary structure, the hydrogen bonding amides within a peptide 
may be identified by performing a quantitative experiment to measure proton exchange rates (5). 
In peptides proton exchange occurs on the amide proton due to the resonance of the amide bond. 
Proton exchange is slowed by participation in hydrogen bonding, thus the significantly slow 
exchange of an amide proton with its solvent is likely to be participating in a hydrogen bond. 
Another valuable piece of information obtainable by NMR is j-coupling. J-coupling is the 
interaction between two nuclear spins which can be measured by the splitting of the resonance 
lines in NMR. These couplings can be measured by how many hertz they span and can be used 
in the Karplus equation to generate torsional angle restraints. Torsional angle restraints may be 
used like distance restraints to provide more information for an MD package to help better refine 
a final structure.  
Lastly, the chemical shift index or CSI can be used as a means to determine if secondary 
structure exists within a peptide or it can be used comparatively to determine if a peptide is 
adopting its intended fold. The CSI is a numerical index which provides information on a 
peptide’s fold by comparison of random coil alpha proton shift values to that of a folded peptide. 
If the shift of alpha proton shift of an experimentally determined peak is +/- 0.1 ppm that peak is 
assigned a CSI value of 0, if the value is greater than 0.1 ppm that peak is assigned a +1 and if 
the peak value is lower than 0.1 ppm in comparison to the random coil value, it is assigned -1. 
Any grouping within the sequence of four or more -1s uninterrupted by 1s is assigned a helix, 
while three or more 1s uninterrupted by -1s is considered a sheet. This technique has shown in 
the literature to be approximately 90% accurate at predicting secondary structure (103). 
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1.5.7  Solution Structure determination of the topological isomers of PnID 
 
As previously mentioned, PnID is a prime candidate to study by NMR due to its small 
size, few PTMs, high homology to F-conotoxins, and propensity to form multiple globular 
isomers. From initial studies of the venom duct material of the Red Sea Conus pennaceus it was 
determined that two disulfide isomers were present, with the largest isomer eluting slightly 
earlier. Synthetic studies in Chapter 2 showed that folding in an ammonium bicarbonate buffer 
created roughly equal forms of both globular and ribbon peptides, with the globular peak eluting 
earlier. It was also determined that selective synthesis of the globular form of PnID resulted in 
two different isomers, indicating that the order of disulfide bond formation was key to achieving 
a unique globular fold. In Chapter 3 it was determined that changes to the oxidation buffer may 
shift formation either to form a higher propensity of ribbon form or the globular form and that 
oxidation under cellular concentrations of glutathione resulted in a larger formation of the ribbon 
isomer, with a still significant portion resulting in the globular form. This previous information 
guided the investigation of the solution structure of PnID, by emphasizing its unique structural 
characteristics. Thus the proceeding portion of this chapter will focus on the structural 
information obtained by NMR on the ribbon and two globular forms of PnID. Since the globular 
is likely to be what is produced within the venom duct and can be produced as two isomers the 
full solution structures of the two globular forms were determined.  
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1.6  Methods 
 
1.6.1 NMR Analysis 
 
Samples for NMR spectroscopy were prepared in a 10% D2O 90% H2O solution pH 3.1 
at concentrations of ~4 mM peptide (>95% purity). A stock solution was prepared by first 
making a pH 2.5 solution working solution and subsequently diluting it with 10% D2O to bring 
the pH to 3.1. Proton 1D spectra were acquired at temperatures ranging from 280 - 298 K. 
Temperatures which yielded the best resolution were used for acquisition of the 2D data. 
TOCSY experiments (eight scans per increment and a 1 s delay between scans) (104) were 
carried out with a 90 ms mixing time and NOESY experiments (sixteen scans per increment and 
a 1 s delay between scans) (105,106) were performed with a 150 ms mixing time. All spectra 
were acquired on a 500 MHz Varian Unity Inova spectrometer using a 3 mm gHX ID probe from 
Varian Associates at 280 K, maintaining the temperature within +/- 1 K. Water suppression was 
achieved using the Double Pulse Field Gradient (DPFG) method of Huang and Shaka (107). 
Spectra were acquired with 256 and 1120 complex data points in the F1 and F2 dimensions 
respectively and zero filled to a final size of 2K by 2K points, Apodization in both dimensions 
was a combination of a 30 degree shifted sine bell and gaussian window functions. The spectra 
were then processed using NMRpipe (108) and MestreNova (109) for Microsoft Windows. 
Assignment of the Spectra was carried out with SPARKY (110). 
5.22 Molecular Modeling 
 
Modeling studies were performed using the NMR module of YASARA Structure (111). 
Conformational restraints were derived from the NOESY spectra and classified as either: strong 
(1.7-2.5 Å), medium (1.7-3.5 Å), weak (1.7-4.5 Å), or very weak (1.7-5.5 Å). Disulfide bonds 
were specified between positions 4,12 and 3,9 for Isomers B and RevB. Pseudo-atom corrections 
were made for methyl and methylene protons according to Wuthrich et al. (5). Each isomer was 
subjected to refinement in explicit solvent using YASARA structure. A total of 50 structures 
were generated and exhibited good convergence. The ensemble of the lowest energy structures 
was validated by PROCHECK-NMR (112,113) 
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1.7 Results 
 
In an attempt to determine differences in favored backbone topologies, the NMR solution 
structures of the two globular (B and RevB) isomers were determined. For each isomer the amide 
signals of the one-dimensional (1D) spectra were well dispersed (between 6.8 and 9.2 ppm) 
which indicated that each isoform contained well-ordered structures. Temperatures that yielded 
the greatest resolution in the amide region were chosen for two-dimensional experiments. The 
isomers yielded 2D spectra of moderate quality, resulting in a sufficient amount of restraints for 
structural modeling. Additional peaks were apparent in lower concentrations than that of the 
expected spin systems however are unlikely to be additional isoforms and could be due to the 
presence of a small amount of contamination. Protons from each residue were assigned using 
TOCSY and NOESY spectra, using a sequential assignment strategy (5) in the program 
SPARKY (110). Secondary shift values, which provide information on the similarity of 
backbone structures among the peptides, were calculated using the observed α proton shifts with 
respect to their random coil values (114). The compared secondary shifts of each isomer are 
shown in Figure 43. 
 
 
Figure 28: The comparative secondary shift values of PnID and PnID RevB. The 
similar shift values from residues 5-12 indicate that the backbone positions are 
conserved in these regions, while positions 1 and 2 appear to be the least 
conserved. The more positive chemical shift values of PnID RevB provide further 
evidence of a higher likely hood of β sheet type character. 
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1.7.1 NMR analysis of PnID B 
 
TOCSY and NOESY connectivity diagrams for PnID B are shown in Figure 29. A stretch 
of NH-Hα peaks were readily identified between residues 3-10 and 12 however the expected 
fingerprint peak from residue 2 was not visible, likely due to rapid amide exchange. A total of 55 
restraints were determined from the NOESY spectra, of which 49 were intra-residue and 16 were 
inter-residue NOEs. 
 
1.7.2  NMR analysis of PnID RevB 
 
TOCSY and NOESY connectivity diagrams for PnID RevB are shown in figure 29. NH-
Hα peaks were identified between residues 2-10 and 12. A total of 63 restraints were calculated 
from the integrated and assigned NOESY spectra, of which 40 were intra-residue and 23 were 
inter-residue NOEs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29: The TOCSY connectivity diagrams of PnID B (4A) and PnID RevB 
(4B) and NOESY sequence walks (4C and 4D).  
 
4B (PnID RevB ) 4A (PnID B) 
4C (PnID B) 4D (PnID RevB) 
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1.7.3  Molecular modeling 
 
In an attempt to better elucidate topological differences between the two globular 
isomers, molecular dynamics simulations were performed on each isomer using calculated 
distance restraints derived from the best NOESY spectra. Sets of 50 structures of each globular 
isomer were generated using Simulated Annealing and energy minimization protocols, and 
explicit refinement in solvent using the YASARA structure NMR module (www.yasara.org). 20 
final structures that corresponded to the lowest energies were chosen to represent the preferred 
solution structure of each peptide. Figure 30 illustrates the determined lowest energy structures 
for each isoform. Structural statistics for each isomer are shown in Table 11 while the entire 
quality assessment for each structure can be seen in Appendix C. PnID B yielded a set of 
structures with a backbone root mean squared deviation (RMSD) from average of 1.409 Å in 
comparison to PnID RevB which yielded a backbone RMSD from average of 1.155 Å. Neither 
set of structures contained any NOE violations greater than 0.5 Å (Table 11).  Positive secondary 
shifts in residues 2-4 and 8-11 RevB (Figure 28) reinforce the notion that a β-type structure could 
exist in this region as was calculated in 7 of the 20 lowest energy models. β-type structure was 
not observed in PnID B despite having similar secondary shifts between residues 4-12. Both 
peptides yielded turns in their ensembles, however due to the proximity of the amide proton in 
arginine 7 to that of the carboxy group of glycine 5 the calculated structures of PnID RevB 
appear to have a higher likelihood of forming a α-turn, whereas due to the distance between the 
carboxy group of cysteine 4 and the amide proton of arginine 7, PnID B appears to have a higher 
propensity to form an J-turn in residues 4-6, similar to what has been reported in other F-
conotoxins. Due to the lower resolution of the data, we were unable to pinpoint the exact 
Ramachandran angles for the residues likely involved in the turns in each of these structures and 
therefore it is not known exactly what type of J- or α-turn may be favored in each peptide. 
Recurring calculated hydrogen bonds within PnID revB also appear to be present between the 
amides of cysteines 3 and 4 and the carboxy portion of methionine 8 possibly indicating stable 
secondary structure within this region. Additionally four long range NOEs were observed in 
PnID RevB as opposed to the single long range NOE seen in PnID B, further increasing the 
likelihood of a β-type structure occurring in PnID RevB but not in PnID B. Additionally both 
PnID B and RevB contained cis-Proline residues, indicating that this conformation is highly 
favored in this peptide, decreasing the likelihood that the isomers may due to cis/trans 
isomerization of Proline.  
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Figure 30: Calculated models of PnID B and RevB. Pane A shows the trace overlay of 
the 20 lowest energy models of PnID RevB. Pane B shows the lowest energy structure of 
PnID RevB. Pane C is a comparison of PnID B and RevB. Pane D shows the trace 
overlay of the 20 lowest energy models of PnID B. Pane E shows the lowest energy 
structure of PnID B. Pane F is the lowest energy structure of F-MrIA. 
A. B. C. 
D. E. F. F. 
105 
 
Table 11: Statistics for the calculated models of PnID RevB and PnID B. 
 
 
 
 
  
 PnID RevB PnID B 
% Backbone angles in favored region 75% 67% 
%  Backbone angles in allowed region 21% 26% 
%  Backbone angles in generously allowed region 4% 8% 
   
Backbone RMSD for all models 0.62 0.5 
   
Violations > 0.3 Å 0 0 
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5.3 Discussion 
 
Comparison between the primary sequence of PnID and that of other F-conotoxins 
reveals that significant differences occur in the second and before the first inter-cysteine loops 
with the Cys-Cys-Gly region of the peptide maintaining complete identity, a region which 
appears to be stabilized by an antiparallel β-sheet in PnID revB, F-MrIA, and F-MrIB (60,115) 
(Table 2) (Figures 29 and 16). All currently known F-conotoxins contain a Valine before the first 
cysteine in the sequence and a Hydroxyproline and Histidine in the final inter-cysteine loop. This 
common characteristic was investigated with respect to the integrity of F-MrIA’s structure 
activity relationships (4). After performing alanine scans it was determined that Valine 3 and 4-
trans-hydroxyproline 12 are critical residues for maintaining stability in F-MrIA. Additionally 
NMR analysis provided insight to hydrophobic interactions that occur between these residues. 
Thus it is likely that the unique placement of Valine and Proline in PnID might aid in its lack of 
preference for a particular connectivity or provides a slight preference for a globular connection. 
The Alanine scan performed on F-MrIA also revealed that the residues between glycine 6 and 
Leucine 9 were of the strongest significance to binding, which represents the most similar region 
to F-PnID (80). In addition to these residues 4-trans-hydroxyproline 12 and Histidine 11 were 
seen to contribute to binding as well albeit in a lessened capacity. 
 
  As previously mentioned, residue replacement on F-MrIA was not only performed by 
alanine scan but also with select residues and multiple replacements on the known contributing 
regions of the molecule, which tested the contribution of size, hydrophobicity, and charge of 
important residue positions within the peptide to its binding affinity with the NET (116). From 
this experiment Bryan-Luka et al. developed a model of the pharamacophore of F-MrIA and 
determined that tyrosine 7 participated in aromatic and hydrogen bonding interactions with the 
receptor and Leucine 9, Histidine 11, and 4-trans-hydroxyproline 12 interacted with a deep 
hydrophobic pocket. Bryan-Luka et al. also found that replacement of Lysine 8 with Arginine 
resulted in a lower activity. PnID however contains arginine in a similar position of the molecule 
but is flanked by a methionine instead of a Leucine. This change in this particular residue 
position could account for the maintenance in affinity for the NET as Methionine has been 
observed to participate in Methionine π interactions with aromatic residues, an interaction which 
has increased favorability over hydrophobic interactions alone (117). 
 
Conotoxins have generally been observed to adopt well-ordered structures whose rigid 
backbone does not radically deviate when binding to an inhibition site (58). This concept has 
especially held true for the well-studied globular α-conotoxins which are highly stabilized by 
disulfide bonds and a characteristic α-helical structure which essentially retains their solution 
structure in both bound and unbound states. The single exception to this however is the α-
conotoxin BuIA, which appears to form a disordered backbone in solution that may attune to 
three separate distinctive conformers, which have evidenced to be Proline cis/trans isomers (56).  
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Topological isomers have been described in various molecules including catenanes, 
rotaxanes, Mobius strips, and knotted molecules (118). Catenanes are molecularly interlocked 
structures such as two rings, rotaxanes are another interlocked structure in which one molecule 
may feed through a ring made by another, and Mobius strips include molecules which form a 
ring with only a single boundary. With the exception of Mobius strips, these motifs are generally 
found in small molecule structures. Knotted molecules, particularly those incorporating cystine 
knots are peptides and are known to undergo topological isomerization involving disulfide 
bonds(119). These topologies are found in peptides containing six cysteines and three disulfides 
and are generally capable of forming three unique topologies known as: the growth factor cystine 
knot (GFCK), the inhibitor cystine knot (ICK), and the cyclic cystine knot (CCK) motifs. The 
GFCK, unlike the other two topologies does not have a disulfide which bisects a ring of two 
other two, instead creating a conformation whose middle disulfide misses the ring entirely. The 
CCK and ICK have similar disulfide connections where a middle disulfide bisects a ring created 
by the other two, however they differ in that the CCK contains a cyclic backbone, while the ICK 
contains free N- and C-termini. Although these topologies have been characterized in three 
disulfide-containing peptides, until now major topological isomers of two-disulfide containing 
peptide toxins have eluded discovery.  
 
Despite the fact that α-conotoxins are all globular peptides, no single instance has yet 
been reported in literature pertaining to the discovery of topological α-conotoxin isomers. Since 
PnID is similar in size to the α-conotoxins it is plausible that topological isomers could exist for 
some if not many sequences. There is mention of an error in co-elution in a synthetically 
produced isomer of Z-conotoxin GVIA to that of a native (134), which may be representative of 
a topological isomer. As the globular form of the α-conotoxins is thought to be the “native” and 
predominantly active form, it would be highly likely that the biological activity of these 
topologies would exhibit significant differences to each other. Thus we suggest that topologies 
be investigated in previously determined α-conotoxins, especially those similar in size to PnID.   
108 
 
The globular form of PnID furthers its uniqueness in that it is capable of forming multiple 
topologies which are likely not due to the cis/trans isomerization of Proline due to the presence 
of characteristic cis Proline NOEs being observed in the spectra for both globular peptides. 
These topologies appear to be characterized by a perturbance of a loop between residues 4/5-7. 
An inverse J-turn has been well characterized as a feature of F-conotoxins and is well 
documented in the solution structures of F-MrIA (115)(Figures 29 and 16). In the case of F-
MrIA, the integrity of the residues which compose this turn was also seen to be critical factor in 
maintaining appropriate binding to the NET, therefore the existence of turns in the globular 
forms of PnID is not surprising. The possible replacement of this turn in the PnID RevB 
topology to an α-turn, however suggests that for this peptide in particular, order of disulfide bond 
formation may play a crucial role in creating an intermediate folding state whose energy may be 
conducive to forming the required hydrogen bonds for creating a stable and active structure once 
folded. This order specific folding strategy could also affect the isomerization of Proline during 
the folding process in the α-conotoxins, as it was not fully investigated in the case of α-BuIA, 
however it is unlikely as it does not appear to be a factor in inducing favorability in the cis/trans 
isomerization of Proline in PnID.  
 
In addition to the perturbance of the critical turn between residues 5-7, the globular 
topologies of PnID show differences in secondary structure. PnID RevB appeared to form a rigid 
beta structure that contains two antiparallel E-sheets whereas PnID B does not appear to contain 
this rigidity. The structure formed by PnID RevB appears to be stabilized by an increased 
capacity to form hydrogen bonds further up in the peptide backbone, thus changing the turn size 
in the area critical to activity (residues 5-8). This is in direct contrast to the PnID B topology 
which has a less rigid region near the termini and the conservation of a J-turn in the critical loop 
(residues 5-7).  
 
A comparison between the globular topologies determined within this work to that of the 
ribbon isoform of F-MrIA revealed that each isoform resembles portions of the F-MrIA 
structure. Comparison between PnID revB and that of F-MrIA (Figure 30) reveals that PnID 
revB retains not only sequence homology in the area surrounding it’s cysteines but also structural 
homology in it’s oxidized form. The key difference in this isomer to that of F-MrIA is the loss of 
the turn in the 5-7 residue region. This is in contrast to that of PnID B which only retains the turn 
and loses the rigid E-type structure.  
 
The differences in structure among the two topological isomers directly explain the 
biological activity determined in Chapter 4 on the monoamine transporters. It has been 
previously noted that the J-turn in F-MrIA is critically important to biological activity and that 
turn appears to be somewhat conserved in the more active globular topology (PnID B), whereas 
this turn is perturbed in PnID RevB. This likely gives rise to the small amount of biological 
activity seen in PnID B and the complete lack of activity in PnID RevB. A similar loss in activity 
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was seen in F-MrIB in which it had an EC50 of about half of that of F-MrIA in a rat vas deferens 
assay, likely due to the promiscuous nature of the same intercysteine loop. In addition to this at 
lower concentrations PnID B appeared to have non-selective inhibition of the monoamine 
transporters whereas PnID RevB appeared to have none. The promiscuity of PnID B could be 
explained by the loss of secondary structure within it’s backbone and thus it’s lack of rigidity.  
 
Biopolymers, especially peptides, have been increasingly becoming important players in 
the pharmaceutical market as novel therapeutics with over 140 leads in clinical trials as of 2015 
(120). Due to this advance in gravity, understanding of how particular crosslinks, residues, inter-
cysteine spacing, and topologies play their role in potency, selectivity, and stabilization is 
becoming an ever more important task. Conus peptides provide great tools for increasing this 
understanding as they are small in size, relatively selective, and contain a significant amount of 
modifications which aid in selectivity and stabilization (31,32).  
 
Despite immense progress in the study of the structure, activity, and folding of α 
conotoxins, as well as an increasing interest in F/O-conotoxins over the past decade, to the best of 
our knowledge native isomers have never been reported until now. Additionally, despite many 
synthetic studies where the disulfide bonds of conotoxins were regio-selectively formed, there 
has never been a report of the production of differential backbone topologies between two 
peptides despite containing identical disulfide bridges.  
 
Since the native isomeric material observed in this study was derived from the venom 
duct of Conus pennaceus and not the organism’s milked venom, it is possible that one of the 
isomers may not be expressed as a functional toxin in the venom and is a consequence of 
inefficient folding within the venom duct. If this is true, there is a possibility that PnID represents 
a less efficient scaffold than other F-conotoxins, and could serve as a transition point between the 
long studied globular fold of the α-conotoxins and that of the ribbon fold seen in previously 
studied F-conotoxins. The significance of this circumstance would be the wider implication that 
by studying the unique folding properties of related conopeptides produced within the venom 
duct, the organism’s route to more efficient scaffolds may be traced and eventually lead to more 
robust methods of rational peptide therapeutic design. 
 
Due to the findings presented here we suggest that future studies involving short, regio-
selectively synthesized and cross-linked peptides such as conotoxins, explicit information should 
be given in the experimental procedures / methods pertaining to which disulfide was formed 
initially so future work is not subject to discrepancies due to resulting differences in topology. 
This work also implies that reported activities or structures of peptides similar in nature to PnID 
may be of non-native or less active topologies and in some cases may be worth reinvestigation. 
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Chapter 6: Future Perspectives  
1.1 Reevaluation of previously discovered conotoxins 
 
Despite thousands of conotoxins having been discovered to date only ~0.1% have had their 
pharmacology extensively studied (121). For decades conotoxin research has carried on in the 
fashion of determining novel sequence, post translational modification, structure, and activity. 
Considering the information presented within this work, it would likely be beneficial to re-
examine some of these previously studied peptides for topological isomerization as it is currently 
unknown if this characteristic is unique to the F-conotoxin scaffold or if it may occur in the more 
extensively studied and more common α-conotoxins which natively adopt the globular disulfide 
bond connectivity and contain only two disulfide bonds. Considering the activity differences in 
the globular isoforms of PnID as seen in chapter four, a second look at the folding capabilities 
and resultant activity of other previously discovered conotoxins could result in differential 
activity and possibly higher potency or selectivity than currently reported.  
 
Many of these peptides have been categorized by their disulfide bond connectivity and 
framework, information that may be used to aid in the synthetic reproduction of these 
conotoxins. Considering the results of this work, it would be beneficial for investigators studying 
conotoxins to not only report disulfide connectivity overall, but also report the order of disulfide 
bond formation during synthetic reproduction. It could also be beneficial to study possible 
differences adopted by folding conotoxins under separate conditions i.e. a single step oxidation 
vs. a multistep oxidation, as we were able to diversify the topology of these toxins using the two 
methods (see Chapter 3). 
 
If previously synthesized conotoxins were to be of less active topologies (i.e. α-conotoxins), 
the implication would be that the production of topological isomers could be used as a means of 
conotoxin diversification, both synthetically and naturally. As was seen in the introduction, PnID 
was originally discovered as two isomers, one of which is highly likely to be a globular isomer 
considering the findings of this work (Chapters 2 and 3). This implies that cone snails may use 
the intrinsic property of topological isomerization as a method to diversify venom naturally.  
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1.2  Rational peptide design 
 
This section contains excerpts from my paper entitled “Conotoxins and their regulatory 
considerations” 
 
As mentioned in Chapter 1, peptides are gaining interest as therapeutics due to their 
selectivity, potency and size. Rational drug design, typically applied to the design of small 
molecule inhibitors to increase both pharmacodynamic and kinetic properties, is beginning to 
find a place in the betterment of potential peptide therapeutics (120). In conotoxins in particular 
rational design has often previously been referred to as peptide bioengineering, a term of 
controversy among some engineers and scientists as it implies that standard engineering 
principles are being applied to the design of these molecules that may not always be the case. 
Nevertheless this term has been extensively used in previously literature. Considering the 
increasing importance of these molecules and their constant subjection to synthetic modification 
it is important to evaluate the capability of these peptides to form alternative topologies. In 
chapter 4 it was discussed how topological differences affected the activity of PnID. If such 
differences can occur in PnID, which is a F-conotoxin and very similar to the α-conotoxins, both 
of which have had significant interest in being developed into therapeutics, topological 
isomerization should be a topic at the forefront of this field. 
 
In Chapter 4, it was seen that at lower concentrations PnID B was able to non-selectively 
inhibit each of the monoamine transporters. If this phenomenon were able to be translated to 
other conotoxins it could potentially open the door for new probes through rational peptide 
design. Alternatively less selective conotoxins that have been previously reported could be re-
evaluated to determine if topological isomerization was a factor in the lack of specificity.  
 
Conotoxins and conopeptides have been the subject of extensive bioengineering and 
chemical manipulation (33). Their ease of synthesis has positioned them as a primary choice 
among peptide chemists who manipulate the native peptide to enhance stability and activity. The 
resulting bioengineered peptide with augmented properties has proved to be an invaluable tool in 
studies pertaining to structural activity relationships, drug leads and ion channel characterization. 
The development of bioengineered conotoxins presents special cases and equivocal situations 
that may require amendments to the current regulations. Conotoxins contain numerous post-
translational modifications (21). These PTMs are responsible for phyla and receptor selectivity. 
Removing some or all of the PTMs can change receptor selectivity (34). Through 
bioengineering, a native conotoxin not active in mammalian receptors can be modified to have 
activity in mammalian receptors. Since conotoxins contain a great deal of PTMs and PTMs are 
known to influence folding in general, the influence of PTMs on topology could be investigated 
in the future to determine what contributions, if any warrant topological differences in these 
peptides. 
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Peptidomimetics has further advanced the field of conopeptide bioengineering. Allowing 
researchers to incorporate synthetic residues or combine active regions of various peptides, 
giving them the ability to create a new peptide with enhanced properties (122). If topological 
isomerization results partially due to the smaller inter-cysteine loop sizes of the F-conotoxins, 
this field could be especially impacted by the formation of unexpected isomers as many 
peptidomimetics include artificial loop sizes. A particular example of this would be the R2-midi 
peptide designed from the P-conotoxins KIIIA and BuIIIC (123). This peptide was synthetically 
designed to contain a pharmacophore for the sodium channel Nav 1.2 and is unnaturally sized. 
Stevens et al. successfully removed a single disulfide bond from this peptide thus not only 
decreasing it’s size but increasing it’s folding efficiency. Such synthetic modifications could 
potentially be subject to topological isomerization and thus should be considered within this 
context.    
 
With the advent of native chemical ligation (NCL) the linking of a peptide’s N-terminus 
to its C-terminus has been successfully performed (124). Conotoxins, with their numerous 
cysteine residues, present themselves as a prime target for peptide backbone cyclization. 
Cyclization is known to enhance the stability of conotoxins. This synthetic strategy has been 
applied to Vc1.1, D-conotoxins AuIB, RgIA and MII using NCL; the cyclized analogs have been 
shown increased oral bioavailability and systemic stability (125-127). In addition to the use of 
synthetic chemistry, cyclization has also been accomplished through advanced molecular biology 
techniques such as interim mediated ligation, which is a potential route for future recombinantly-
produced cyclic conotoxins (128). Backbone cyclization, especially in terms of non-native 
backbone cyclization could potentially exhibit topological effects as it often requires the 
inclusion of a linker sequence between the N- and C-termini and thus changes the intercysteine 
loop size of this region. Now that many α-conotoxins are undergoing the cyclization process in 
the hope of creating more “drug-like” peptides, topological isomerization could very likely be 
occurring in some of these products.  
 
Another approach to increase the in vivo stability is using cystathionine and dicarba 
linkages in replacement to essential disulfide bonds. This approach has been successfully applied 
in α-conotoxin ImI (129). Enhancing oral stability of conotoxins provides a new route of 
administration and hence requires a reassessment of current conotoxin directives. Inclusion of 
such bonds in these peptides have specific effects on bond length, as a cystathionine bond, 
dicarba linkage, or diselenide bond would differ slightly in length to that of traditional disulfides. 
These slight changes in bond length could potentially change the favorability of bond formation 
and thus produce alternative topologies. Therefore topological isomers should also be considered 
with these particular modifications as they may provide unique biological activities.   
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As all of these forms of modification are gaining in popularity, a look into their effect on 
topological isomerization would be worth pursuing. If topological isomerization is unique to that 
of the F-conotoxin scaffold it would be of interest to determine what differences are causing this 
phenomenon and if those differences could be mimicked, either deliberately or by indirect 
causation.  Considering the many facets affected by topological isomerization, it is important 
when synthetically producing either a native sequence or a rationally designed globular peptide 
to consider the order of disulfide bond formation and ensure that the appropriate order is 
followed to produce the intended topology.  
 
Another area of interest that may aid in our understanding of topological isomer 
formation and thus better future rational peptide design is that of the study of the pro regions of 
conotoxins and their relationship to molecular chaperones within the venom duct. It has been 
previously determined that pro regions of these peptides serve as anchor sites to PDIs which aid 
in efficiently folding conotoxins (130). Despite being only one of many potential mechanisms 
which aid in folding, the contribution of these highly conserved sequences to achieving not only 
the appropriate disulfide connectivity but also the appropriate topological motif should not be 
ignored. 
 
Many techniques have been adapted in recent years to aid in the rational design of 
peptides, not the least of which are the previously discussed alanine scans, NMR solution 
structure determination, and crystallography. However In addition to traditional structure 
determination real time disulfide bond connectivity analysis may be a beneficial technique for 
determining which disulfide bond may be more thermodynamically stable within a peptide, thus 
potentially providing differential information on topological isomers. Partial reduction and 
alkylation, a procedure developed by Gray et al. (131) is a technique commonly used to 
determine the connectivity of disulfides within peptides and proteins. This process entails using a 
reducing agent along with a small amount of heat to sequentially break individual disulfide bond 
while sparing others (131). This technique takes advantage of the slight differences in bond 
energies throughout the disulfides of the peptide, and yields largely varied results depending on 
the peptide sequence under investigation. There are several potential reducing agents which may 
be used to selectively break the disulfide bonds/bridges, however TCEP is generally favored due 
it’s fast reaction time, pH range compatibility, and it’s lack of odor (Table 3), in addition, unlike 
other reducing agents TCEP does not reduce the cystine through a mixed disulfide intermediate 
but by a thiophosphonium intermediate (132). During the reduction process it is possible to 
monitor the reaction when using very low concentrations of the reducing agents. Monitoring may 
be done in real-time by direct injection of the reactants into an electrospray ionization mass 
spectrometer (ESI-MS) and scanning at a narrow mass window (+/- 10 m/z) for the respective 
reduced masses (133). Once a single bond is broken the peptide, resulting in a mass shift has 
demonstrated by boarding of the mono-isotopic distrubtion, it then is acidified to prevent the 
reformation, or scrambling of the disulfide and the ‘captured’ free thiols are then alkylated.    
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Various alkylating agents are available for this process and each carry particular 
advantages and disadvantages, however the use of iodoacetamide and vinyl pyridine, the 
reagents originally used by Gray et al. (131), are commonly used. After alkylation the peptide 
that contains the alkylated target mass of interest is then purified from the reaction mixture by 
reverse-phase high pressure liquid chromatography (RP-HPLC/UV). This process is then 
sequentially repeated for other disulfides and exposed to a different alkylating agent with a 
unique mass addition with respect to the previous alkylating agent(s).  Finally the peptide is then 
sequenced and the corresponding ‘matching’ cysteinyl functions are considered to have been 
previously shared a single disulfide bond (Figure 3). Sequencing approach, resulting in disulfide 
bond assignment, may be taken a number of ways: Originally done by Gray et al. (131) use of 
Edman degradation on RP-HPLC purified products, while Bingham et al. (133), used original 
MS/MS to deduce disulfide bond connectivity.  Notably, if Edman degradation is being used on 
a cyclic peptide, that peptide must first be cleaved enzymatically as the Phenylisocyanate will 
have no free termini to react with – this is a potential hurdle. If there are no potential cleavage 
sites for the peptide MS/MS or PSD should be the sequence method of choice – fragmenting 
along the peptide backbone, but paying special attention to sequence analysis. 
 
Therefore from the findings of this work we believe that topological isomerization could 
be a major influencing factor to many different areas regarding the future of peptides as 
molecular probes, drugs, and even potentially pesticides. As peptides begin to garner more 
interest with higher levels of rational design and a push for better pharmacokinetic properties we 
may see an increased risk of inappropriate topological isomerization. Thus careful consideration 
must be taken when planning a synthetic oxidation strategy, the inclusion of synthetic residues or 
PTMs, the alteration of loop sizes, cyclization, or alternative disulfide strategies. Finally, 
techniques such as co-elution as seen in Chapter 2, differential activity as seen in Chapter 4, 
crystallography or solution structure determination as seen in Chapter 5, and real time disulfide 
bond analysis as discussed in this chapter should be considered to aid in the elucidation of these 
isoforms.    
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Appendices: 
Appendix A.  Crude and purified Chromatograms of the PnID isomers 
 
 
1: RP-HPLC/UV chromatogram of the crude PnID containing no orthogonal protection.  
 
 
 
2: RP-HPLC/UV chromatogram of the crude CMrVIA containing no orthogonal protection.  
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3: RP-HPLC/UV chromatogram of the crude MrIA containing no orthogonal protection.   
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4: RP-HPLC/UV chromatogram of crude PnID B containing two orthogonally protected ACM 
cysteines and two cysteines with free thiols. 
 
 
 
5: RP-HPLC/UV chromatogram of crude PnID C containing two orthogonally protected ACM 
cysteines and two cysteines with free thiols. 
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6: RP-HPLC/UV chromatogram of crude PnID RevA containing two orthogonally protected 
ACM cysteines and two cysteines with free thiols. 
 
 
7: RP-HPLC/UV chromatogram of crude PnID RevB containing two orthogonally protected 
ACM cysteines and two cysteines with free thiols. 
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8: RP-HPLC/UV chromatogram of the fully folded and purified form of PnID B. 
 
 
9: RP-HPLC/UV chromatogram of the fully folded and purified form of PnID C. 
  
AU
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
Minutes
20.00 22.00 24.00 26.00 28.00 30.00 32.00 34.00 36.00 38.00 40.00 42.00 44.00 46.00 48.00 50.00
AU
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
Minutes
20.00 22.00 24.00 26.00 28.00 30.00 32.00 34.00 36.00 38.00 40.00 42.00 44.00 46.00 48.00 50.00
129 
 
 
 
 
10: RP-HPLC/UV chromatogram of the fully folded and purified form of PnID RevA. 
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Appendix B.  Mass spectra of the crude and purified PnID isomers 
 
 
 
 
1: Mass spectrograph of the fully folded PnID containing no orthogonal protecting groups. 659.6 
was the observed mass to charge ratio (m/z) in the second charge state. The expected m/z in this 
charge state was 660 +/- 0.5 . 
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2: Mass spectrograph of the fully folded PnID A containing no orthogonal protecting groups. 
660.3 was the observed mass to charge ratio (m/z) in the second charge state. The expected m/z 
in this charge state was 660 +/- 0.5 . 
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3: Mass spectrograph of the fully folded PnID B containing no orthogonal protecting groups. 
660.3 was the observed mass to charge ratio (m/z) in the second charge state. The expected m/z 
in this charge state was 660 +/- 0.5 . 
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4: Mass spectrograph of the fully folded PnID C containing no orthogonal protecting groups. 
660.3 was the observed mass to charge ratio (m/z) in the second charge state. The expected m/z 
in this charge state was 660 +/- 0.5 . 
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5: Mass spectrograph of the fully folded PnID RevA containing no orthogonal protecting groups. 
660.2 was the observed mass to charge ratio (m/z) in the second charge state. The expected m/z 
in this charge state was 660 +/- 0.5 . 
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6: Mass spectrograph of the fully folded PnID RevB containing no orthogonal protecting groups. 
660.2 was the observed mass to charge ratio (m/z) in the second charge state. The expected m/z 
in this charge state was 660 +/- 0.5 
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Appendix C.  Model quality assessment of the submitted PnID structures 
 
The following figures are the results of the verification software used by the World Wide Protein 
Databank (wwPDB) to assess the quality of the structures and determine if they are acceptable 
for deposition within the wwPDB. 
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